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Abstract 
 
Obesity is a key factor contributing to the “metabolic syndrome” which increases the risk 
for type 2 diabetes, cardiovascular disease and liver complications. In obese conditions, 
lipotoxicity is a serious concern as the accumulation of lipids and lipid-intermediates in non-
adipose tissue such as skeletal muscle, heart, liver and pancreas, leads to cellular dysfunction 
and activation of stress responses. In this study, I have examined how palmitate-induced 
lipotoxicity, effects the cellular processes ER stress, autophagy and apoptosis, in L6 rat skeletal 
muscle cells. I have elucidated cross-talk mechanisms between these processes, and have 
demonstrated that palmitate induces excessive protein accumulation, thereby stimulating ER 
stress, activation of the UPR and subsequent apoptosis. Autophagy may be recruited as a 
compensatory mechanism to help the cell cope with the stress of protein overload through its 
degradative pathway. Additionally, adiponectin may increase autophagic flux, thereby 
contributing to cytoprotective effects of reducing ER stress and apoptosis.  
 
 
 
 
 
 
 
 
 
 
 
iii 
 
Acknowledgements 
 I would like to take this opportunity to first and foremost thank Dr. Gary Sweeney, my 
supervisor, whose constant support, encouragement and advice, I will always be grateful for. It 
is with his guidance, expertise and patience that I have been able to arrive at this milestone in 
my academic career and his good nature, humor and steady backing have made the journey a 
truly valuable, enjoyable experience that has helped me to realize my potential as a researcher.  
 
 Next, I would like to express my heartfelt gratitude to my committee members: Dr. John 
McDermott, Dr. Andrew Donini, Dr. Chun Peng and Dr. Michael Connor, for their time and 
support in the discussion and revision of my thesis. Thank you also to my in-lab supervisors, Dr. 
Min Park and Dr. Subat Turdi for their meticulous efforts in training and advising me.  
 
 A very big thank you to all past and present members of the Sweeney Lab. Your 
friendship and day-to-day support has meant so much to me during the past two years and I 
could not have made it to this point without you. A special thank you to Penny Ahlstrom, 
Sanjana Sen, Dr. Keith Dadson, Dr. Carol Chan and Dr. Helen Chasiotis for always being there 
for me and willing to lend a helpful hand, or an attentive ear. Thank you to Dr. Scott Kelly, 
Adrienne Dome and Cristalina Del Biondo for your behind-the-scenes support at the university 
and to the Go Safe staff for keeping me safe on the late nights.  
 
 Lastly, but not in the least, a sincere thank you to my loving family. To my parents, 
Daniel and Elizabeth Rai, for their love and steadfast support of my endeavours, to my sister 
Desiree Chester, for constantly inspiring and motivating me, to my brother-in-law, Trevor 
Chester, for being my continued cheerleader, and to my boyfriend, Danny Ray Dadula, who 
held my hand throughout, thank you. This could not have been possible without you all.  
iv 
 
Table of Contents  
  
  
Abstract  ii 
Acknowledgements  iii 
Table of Contents  iv 
List of Abbreviations viii 
List of Figures  xii 
     
     
Chapter 1: Introduction  
  
1.1 The Prevalence and Health Risks of the Obesity Epidemic 1 
   
1.2 Adipose Tissue, Skeletal Muscle and the Consequences of Increased Adiposity  2 
   
 1.2.1 Insulin Resistance 3 
 1.2.2 Inflammation and Adipokine Imbalance 6 
 1.2.3 Skeletal Muscle Myopathies  7 
    
1.3 Stress-Activated Cellular Responses Induced by Obesity: ER Stress, Autophagy 
and Apoptosis 8 
   
 1.3.1 ER Stress 9 
  1.3.1.1 Function and Signalling Pathway 9 
  1.3.1.2 Role in the Complications of Obesity 11 
     
 1.3.2 Autophagy 13 
  1.3.2.1 Function and Mechanisms 13 
  1.3.2.2 Role in the Complications of Obesity 16 
     
 1.3.3 Apoptosis 18 
  1.3.3.1 Function and Regulatory Mechanisms 18 
  1.3.3.2 Role in the Complications of Obesity 21 
     
1.4 Cross-talk and Links Between ER Stress, Autophagy and Apoptosis 23 
   
 1.4.1 ER Stress Induces Autophagy as a Rescue Mechanism 23 
 1.4.2 Prolonged or Excessive ER Stress Induces Apoptosis 24 
    
 1.4.3 Interplay between Autophagy and Apoptosis 26 
  1.4.3.1 Autophagy Precedes and Inhibits Apoptosis 26 
  1.4.3.2 Apoptosis Inhibits Autophagy beyond a Critical Threshold of 
Stress 27 
  1.4.3.3 Autophagy Induces Cell Death via Apoptosis, Independent of 
Autophagic Cell death 27 
  1.4.3.4 Autophagy Protects Against ER Stress-Induced Apoptosis 28 
    
 
  
v 
 
1.5 Adiponectin 29 
    
 1.5.1 Structure 29 
 1.5.2 Role in the Complications of Obesity and Functional Significance 29 
    
1.6 Research Objectives, Experimental Model and Hypothesis 33 
     
     
Chapter 2: Materials and Methods   
  
2.1 Cell Culture and Treatment of L6 cells 34 
2.2 Thioflavin T (ThT) Fluorescence Assay 35 
2.3 GRP78mcherry Fluorescence Microscopy and Quantification 36 
2.4 Cell Lysis and Western Blotting 37 
2.5 Endogenous LC3 Immunofluorescence Microscopy 38 
2.6 Magic Red Cathepsin B Assay for Lysosomal Activity 38 
2.7 Inhibition of Autophagy using ATG5K130R Dominant Negative Mutant 39 
2.8 Caspase 3/7 Green Detection Reagent Assay  40 
2.9 MTT Assay  40 
2.10 Statistical Analysis 41 
  
  
Chapter 3: Effect of Palmitate on ER Stress, Autophagy and Apoptosis and 
Regulation by Adiponectin   
  
3.1 Effect of Palmitate on ER Stress and Autophagy  42 
   
 3.1.1 Introduction 42 
 3.1.2 Results  45 
    
  3.1.2.1 Palmitate induces ER stress, as evidenced by increased 
cellular protein aggregation, increase in GRP78mcherry 
expression and upregulation of the UPR 45 
     
  3.1.2.2 Palmitate appears to increase autophagic flux, as evidenced by 
apparent increased autophagosome formation and lysosome 
activity 49 
    
     
3.2 ER Stress May Induce Autophagy as a Rescue Mechanism  53 
   
 3.2.1 Introduction 53 
 3.2.2 Results  55 
    
  3.2.2.1 Tunicamycin, an established inducer of ER stress, appears to 
increase autophagic flux as evidenced by Western blotting for 
autophagic proteins and apparent increase in lysosomal activity 55 
     
     
vi 
 
  3.2.2.2 Sustaining UPR activity and preventing dephosphorylation of 
eIF2α with ER stress inhibitor salubrinal, appears to increase 
lysosomal activity, as assessed by Magic Red Cathepsin B 
assay microscopy 60 
     
  3.2.2.3 Inhibiting autophagy using ATG5K130R dominant negative cell 
line or pharmacological inhibitor, chloroquine appears to 
increase ER stress, as evidenced by apparent increases in 
protein aggregation and UPR stimulation     62 
  
  
3.3 Prolonged, Excessive, or Uninhibited ER Stress Induces Apoptosis   68 
   
 3.3.1 Introduction 68 
 3.3.2 Results  70 
    
  3.3.2.1 Tunicamycin and palmitate, both stimulators of ER stress, 
appear to induce apoptosis by activating caspase activity, as 
evidenced by Western blotting 70 
     
  3.3.2.2 Apoptosis induced by palmitate may be exacerbated by 
inhibiting autophagy with chloroquine, and may be ameliorated 
by inhibiting ER stress through sustaining peIF2α UPR pathway 
with salubrinal, as evidenced by caspase activity and MTT cell 
viability assay 73 
  
  
3.4 Adiponectin Regulates ER Stress, Autophagy and Apoptosis   78 
   
 3.4.1 Introduction 78 
 3.4.2 Results  80 
    
  3.4.2.1 Adiponectin appears to increase autophagy, as evidenced by 
apparent increased autophagosome formation and lysosome 
activity 80 
     
  3.4.2.2 Adiponectin appears to reduce ER stress induced by palmitate, 
as evidenced by apparent decreased cellular protein 
aggregation and GRP78mcherry expression 83 
     
  3.4.2.3 Adiponectin reduces apoptosis induced by palmitate, as 
assessed by Caspase 3/7 Green Detection Reagent 
Microscopy 86 
   
Chapter 4: Discussion   
    
4.1 Effect of Palmitate on ER Stress and Autophagy  88 
4.2 ER Stress May Induce Autophagy as a Rescue Mechanism 89 
4.3 Prolonged, Excessive, or Uninhibited ER Stress Induces Apoptosis   91 
4.4 Adiponectin Regulates ER Stress, Autophagy and Apoptosis   94 
vii 
 
Chapter 5: Summary  
   
5.1 Overview of Results  97 
5.2 Future Directions  99 
5.3 Concluding Remarks  102 
     
     
References  103 
  
Appendix A: List of Contributions 1 
  
Appendix B: Permissions for use of adapted or reproduced figures from articles 2 
  
     
     
     
     
     
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
viii 
 
List of Abbreviations 
 
3-MA 3-Methyladenine 
ACD Autophagic cell death 
ACS Acyl CoA synthase 
Ad Adiponectin 
AdipoR Adiponectin receptor 
AdKO Adiponectin knockout 
ADP Adenosine diphosphate 
AIF Apoptosis-inducing factor 
AMBRA1 Activating molecule in BECN1-regulated autophagy 1 
AMEM Alpha-minimum essential medium 
AMPK Adenosine monophosphate-activated protein kinase 
ANGPTL2 Angiopoietin-like protein 2 
ANOVA Analysis of variance 
APAF1 Apoptotic protease-activating factor 1 
ASK Apoptosis signal-regulating kinase 
ATF Activating transcription factor 
ATG Autophagy protein 
ATP Adenosine triphosphate 
BAK BCL-2 antagonist or killer 
BAX BCL-2-associated X protein 
BCA  Bicinchoninic acid  
Bcl-2 B cell lymphoma 2 
BH3 Bcl-2 homology domain 3 
BID BH3-interacting to domain death agonist 
BiP Binding immunoglobulin protein 
BMI Body mass index 
BSA Bovine serum albumin 
C/EBP CCAAT/enhancer-binding protein 
CAD Caspase-activated DNase 
CCL2 (C-C motif) chemokine ligand 2 
CDC Cell division cycle protein 16 homolog 
Chl Chloroquine 
CoA Coenzyme A 
CHOP CCAAT/enhancer-binding protein homologous protein 
CIH Chronic intermittent hypoxia 
CV Cresyl violet 
CXCCL5 (C-X-C motif)-chemokine ligand 5 
DAG Diacylglycerols 
DAPI 4’,6-diamidino-2-phenylyindole 
DMSO Dimethyl sulfoxide 
DTT Dithithreitol 
EMCL Extramyocellular lipids 
eIF2 Eukaryotic translation initiation factor 2 
EndoG Endonuclease G 
ER Endoplasmic reticulum 
ERA ER-containing autophagosomes 
ERAD ER-associated degradation 
Ero1 ER oxidoreductin 1 
ix 
 
EV Empty vector 
FA Fatty acid 
fAd Full length adiponectin 
FAK Focal adhesion kinase 
FADD Fas-associated protein with death domain 
FasL Fas ligand 
FasR Fas receptor 
FBS Fetal bovine serum 
FFA Free fatty acid 
FIP200 FAK family kinase-interacting protein of 200 kDa 
gAd Globular adiponectin 
GADD34 Growth arrest and DNA damage-inducible protein 34 
GAP GTPase-activating protein 
GFP Green fluorescent protein 
GLUT4 Glucose transporter type 4 
GRP78 Glucose-regulated protein 
GTP Guanosine-5’-triphosphate  
H2O2 Hydrogen peroxide 
HEK293 Human embryonic kidney 293 cells 
HFD High-fat diet 
HMW High molecular weight 
HRP Horse-radish peroxidase 
ICAD Inhibitor of CAD 
IKKβ IκB kinase 
IL Interleukin 
IMCL Intramyocellular lipids 
iNOS Inducible nitric oxide synthase 
IR Insulin receptor 
IRE1 Inositol-requiring enzyme-1 
IRS Insulin receptor substrate 
JNK c-Jun N-terminal kinases 
LAMP-2A Lysosome-associated membrane protein type 2A 
LC3 Microtubule-associated protein 1A/1B-light chain 3 
LMW Low molecular weight 
MAPK Mitogen-activated protein kinase 
MCP1 Monocyte chemoattractant protein 1 
MEF Mouse embryonic fibroblast 
MMW Medium molecular weight 
MOMP Mitochondrial outer membrane permeabilization 
mtDNA Mitochondrial DNA 
mTORC2 Mammalian target of rapamycin complex 2 
MTS 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium 
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium  
MuRF1 Muscle RING-finger protein 1 
NaF Sodium fluoride 
NAMPT Nicotinamide phosphoribosyltransferase 
NCK Noncatalytic region of tyrosine kinase 
NF-κB Nuclear factor-κB 
NLRP3 NOD-like receptor 
NO Nitric oxide 
x 
 
NOD Nucleotide-binding oligomerization domain 
PAGE Polyacrylamide gel electrophoresis 
Pal Palmitate 
PARP Poly ADP ribose polymerase 
PAS Pre-autophagosomal structure 
PBS Phosphate-buffered saline 
PDK Phosphoinositide-dependent kinase 
PE Phsphatidylethanolamine 
peIF2α Phospho-eIF2 alpha 
PERK Protein kinase-like ER kinase 
PH Pleckstrin-homology 
PI3K Phosphatidylinositol-3-kinase 
PINK1 PTEN-induced putative kinase 1 
PIP2 Phosphatidylinositol 4,5-bisphosphate 
PIP3 Phosphatidylinositol 3,4,5-triphosphate 
PKB Protein kinase B 
PKC Protein kinase C 
PolyQ72 Polyglutamine 72 
PP1 Protein phosphatase 1 
PPARα Peroxisome proliferator-activated receptor alpha 
pPERK Phospho-PERK 
PTB Phosphotyrosine-binding 
PTEN Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase 
PVDF Polyvinylidene fluoride 
Rap Rapamycin 
RBP4 Retinol-binding protein 4 
RFP Red fluorescent protein 
RIP Ribosome inactivating protein 
RIPA Radioimmunoprecipitation 
ROS Reactive oxygen species 
Sal Salubrinal 
SDS Sodium dodecyl sulfate 
SEM Standard error of the mean 
SERCA Sarco/ER Ca2+-ATPase 
SFRP5 Secreted frizzled-related protein 5 
SH2 Src homology 
siRNA Small interfering RNA 
SMAC Second mitochondria-derived activator of caspase 
TG Triacylglycerol 
ThT Thioflavin T  
TBC1D4 (tre-2/USP6, BUB2, cdc16) domain family member 4 
TEM Transmission Electron Microscopy 
TNF Tumour necrosis factor 
TRAD TNF receptor type 1-associated death domain 
TRAF2 TNF receptor-associated protein factor 2 
TUNEL Terminal deoxynucleotidyl transferase dUTP nick end labeling 
TZD Thiazolidinedione 
UCP Uncoupling protein 
ULK1 UNC-51-like kinase 1 
UPR Unfolded protein response 
USP6 Ubiquitin specific peptidase 6 
xi 
 
VMP1 Vacuole membrane protein 1 
VPS34 Vacuolar protein sorting 34 
WHO World Health Organization 
wt Wild type  
XBP1 X-box binding protein 1 
XIAP X-linked inhibitor of apoptosis protein 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xii 
 
List of Figures 
 
Chapter 1: Introduction    
  
Figure 1.1. Regulation of insulin-stimulated glucose uptake 5 
  
Figure 1.2. ER stress and activation of the UPR pathways 11 
  
Figure 1.3. The major stages of autophagy 16 
  
Figure 1.4. The two main pathways for the initiation of apoptosis  21 
  
  
Chapter 3: Effect of Palmitate on ER Stress, Autophagy and Apoptosis and 
Regulation by Adiponectin   
  
Figure 3.1. Palmitate induces ER stress by increasing cellular protein aggregation, as 
assessed by ThT Assay. 46 
  
Figure 3.2. An increase in GRP78mcherry expression provides evidence for induction of 
ER stress by palmitate 47 
  
Figure 3.3. Palmitate demonstrates a trend towards upregulating UPR marker peIF2α, 
as assessed by Western blot 48 
  
Figure 3.4. Palmitate appears to increase autophagosome formation, as assessed by 
endogenous LC3 puncta immunofluorescence (IF) microscopy 50 
  
Figure 3.5. Palmitate may increase lysosome activity, as assessed by Magic Red 
Cathepsin B Assay microscopy 51 
  
Figure 3.6. Palmitate demonstrates a trend towards increasing autophagic flux, as 
assessed by Western blot for LC3II and p62 52 
  
Figure 3.7. Tunicamycin demonstrates a trend towards upregulating UPR marker 
peIF2α, as assessed by Western blot 57 
  
Figure 3.8. Tunicamycin, an inducer of ER stress, demonstrates a trend towards 
increasing autophagic flux, as assessed by Western blot for LC3II and p62 58 
  
Figure 3.9. Tunicamycin, an inducer of ER stress, appears to increase lysosomal 
activity, at 4h but not 24h, as assessed by Magic Red Cathepsin B Assay microscopy 59 
  
Figure 3.10. Sustaining UPR activity by preventing dephosphorylation of eIF2α with ER 
stress inhibitor salubrinal, may increase lysosomal activity, as assessed by Magic Red 
Cathepsin B Assay microscopy 61 
  
Figure 3.11. ATG5K130R myoblasts appear to demonstrate impaired autophagy, as 
assessed by Western blot for LC3II and p62 64 
  
xiii 
 
Figure 3.12. ATG5K130R cells appear to demonstrate increased protein aggregation, 
as assessed by ThT microscopy assay 65 
  
Figure 3.13. ATG5K130R myoblasts demonstrate increased expression of UPR marker, 
peIF2α, as assessed by Western blot 66 
  
Figure 3.14. Inhibiting autophagy with chloroquine increases GRP78mcherry 
expression and induction of ER stress 67 
  
Figure 3.15. Tunicamycin, an inducer of ER stress, may increase caspase 12, as 
assessed by Western blot 71 
  
Figure 3.16. Palmitate and tunicamycin, both stimulators of ER stress, demonstrate a 
trend towards increasing cleaved caspase 3, as assessed by Western blot in L6 wt 
myotubes 72 
  
Figure 3.17. Apoptosis in L6 wt myoblasts as assessed by cleaved caspase 3 Western 
blot 75 
  
Figure 3.18. Apoptotic cells, as assessed by Caspase 3/7 Green Detection Reagent 
Microscopy 76 
  
Figure 3.19. Cell viability as assessed by MTT Assay in L6 wt myoblasts 77 
  
Figure 3.20. Analysis of autophagic flux markers, LC3II and p62 by Western blot 81 
  
Figure 3.21. Adiponectin appears to stimulate autophagy as evidenced by Magic Red 
Cathepsin B Assay microscopy 82 
  
Figure 3.22. Adiponectin may demonstrate a trend towards reducing protein 
aggregation caused by palmitate’s induction of ER stress, as assessed by ThT Assay 84 
  
Figure 3.23. Adiponectin reduces GRP78mcherry expression in palmitate condition, 
providing evidence that it may reduce the ER stress induced by palmitate 85 
  
Figure 3.24. Adiponectin reduces apoptosis caused by palmitate, as assessed by 
Caspase 3/7 Green Detection Reagent Microscopy 87 
  
  
Chapter 5: Summary  
  
Figure 5.1. Effect of palmitate-induced lipotoxicity on ER stress, autophagy and 
apoptosis and regulation by adiponectin in L6 skeletal muscle cells 98 
 
  
 
1 
 
Chapter 1: Introduction 
 
1.1. The Prevalence and Health Risks of the Obesity Epidemic 
 
Over the past decades, with an increase in caloric intake and sedentary lifestyle, obesity 
has risen to become a global pandemic [1]. Categorized as a body mass index (BMI) of over 30 
(i.e. weight (kg)/height (m2)), a 2008 evaluation by the World Health Organization has estimated 
that 500 million adults aged 20 or older worldwide are obese and 900 million are overweight 
(BMI of 25.0-29.9). This means that approximately 35% of the global adult population are 
overweight or obese, and indicates that since 1980, obesity rates have doubled [2].  
 
This trend is well represented in Canada, with the overall prevalence of obesity having 
increased from 10% in 1970 to 23% in 2004 (i.e. 8% to 23% in men and 13% to 22% in women) 
[3]. Another report states that between 1985 and 2011, the prevalence of adult obesity in 
Canada has escalated from 6.1% to 18.3%. Breaking it down, there has been an increase from 
5.1% to 13.1% in individuals with a BMI of 30.0–34.9 (obese class I), from 0.8% to 3.6% in the 
BMI group of 35.0–39.9 (obese class II), and from 0.3% to 1.6% in those with BMI of ≥ 40.0. 
Furthermore, it is predicted that by 2019, adults classified as overweight or obese are predicted 
to outnumber normal-weight adults in half of the Canadian provinces [4]. 
 
These alarming increases are particularly disconcerting as obesity is known to lead to 
numerous adverse disorders such as dyslipidemia, hypertension and glucose intolerance. Such 
abnormalities which are often grouped under the umbrella term “metabolic syndrome” increase 
the risk for cardiovascular disease, type 2 diabetes and liver complications such as non-
alcoholic fatty liver disease [5]. In addition, obesity has been linked with gastrointestinal and 
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reproductive cancers, osteoarthritis and sleep apnea. Collectively, these mean that obesity 
reduces life expectancy, increases disability and impairs productivity [1].  
 
1.2. Adipose Tissue, Skeletal Muscle and the Consequences of Increased 
Adiposity  
 
 
Adipose tissue consisting of adipocytes, endothelial cells, fibroblasts, leukocytes and 
macrophages is primarily found in subcutaneous and visceral depots, but it also occurs in 
organs such as the heart and kidneys, and in the bone marrow, lungs and the adventitia of 
major blood vessels [6]. One of the chief functions of adipose tissue is to sequester excess fuel 
as fat in adipocytes. In conditions of obesity however, adipocytes experience challenges and 
limitations on their lipid storage and processing capabilities. Beyond a critical threshold, the 
adipocyte begins exhibiting signs of stress, including hypertrophy and mechanical stress, 
hyperplasia, compositional changes of lipids and other nutrients, hypoxia, disruption of 
mitochondrial function, production of reactive oxygen species, apoptotic signaling, increased 
fatty acid (FA) release, altered adipokine signaling, inflammation and endoplasmic reticulum 
(ER) stress. Overlap occurs between several of these processes – many of them feeding into 
and influencing each other to contribute to the development of metabolic dysfunction [7].  
 
Many studies have found that the excess circulating fatty acids in the blood plasma of 
obese individuals lead to the deposition of lipids or lipid-intermediates in non-adipose tissue 
such as heart and skeletal muscle, liver and pancreas [8-10]. In skeletal muscle, lipids are 
categorized as extramyocellular lipids (EMCL) which are localized in adipose cells between 
myofibers, and intramyocellular lipids (IMCL) which are found within muscle cells. IMCL consist 
of lipid droplets containing triacylglycerols (TAG) and cholesterol esters, as well as lipid 
metabolites, such as long-chain acyl CoAs, diacylglycerols (DAG) and ceramides. Both EMCL 
and IMCL expand in obese conditions, causing buildup of lipid byproducts and consequent 
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lipotoxic effects. Indeed, elevated TAG content and greater numbers of lipid droplets have been 
documented in muscle biopsies from obese people, while long-chain acyl CoAs, diacylglycerols 
and ceramides have been noted to accumulate in skeletal muscle of obese humans, genetically 
obese mice (ob/ob and db/db) and obese Zucker rats [11].  
 
Investigating the biological effects of excessive lipids on skeletal muscle is of particular 
interest because the changes in cell signaling that are induced bring about adverse outcomes 
such as insulin resistance and inflammation. These metabolic consequences are especially 
important in this tissue as skeletal muscle is the primary site of insulin-stimulated glucose 
disposal [12]. An additional point of concern that is gaining more recognition in recent years, is 
the observation that excessive adiposity can lead to apoptosis and atrophy, which is involved in 
the development of various skeletal muscle myopathies that are often observed in obese 
patients [13].  
 
 
1.2.1. Insulin Resistance 
 
 
Approximately 45% of lean body mass is composed of skeletal muscle, which 
collectively accounts for about 80% of insulin-stimulated glucose disposal in the body. With 
skeletal muscle being such a major contributor to whole-body energy expenditure, its 
responsiveness to insulin is crucial for regulating whole-body insulin sensitivity [14-16]. In 
healthy individuals, insulin promotes glucose uptake through a cascade of phosphorylation 
events that culminate in the translocation of GLUT4 transporters from the cytoplasm to the 
plasma membrane, which then allow glucose to enter the cell [12, 17]. 
 
Insulin binds to the α subunit of its insulin receptor (IR), inducing a conformational 
change that results in the autophosphorylation of tyrosine residues present in the β subunit [18]. 
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Members of the insulin receptor substrate family (IRS) then bind to IR via phosphotyrosine-
binding (PTB) domains [19]. Receptor binding leads to the phosphorylation of key tyrosine 
residues on IRS proteins, which then bind to downstream substrates such as class I 
phosphatidlyinositol-3-kinase (PI3K) through the Src homology 2 (SH2) domain of the p85 
regulatory subunit. The catalytic subunit p110 is then activated and phosphorylates lipid 
substrates such as phosphatidylinositol 4,5-bisphosphate (PIP2) to form phosphatidylinositol 
3,4,5-triphosphate (PIP3) at the plasma membrane. Akt is recruited to the plasma membrane 
via pleckstrin-homology (PH) domain interaction with PIP3, and a conformational change in Akt 
occurs that allows its subsequent phosphorylation. Specifically, interaction with the activating 
kinase phosphoinositide-dependent kinase (PDK) phosphorylates Akt at threonine (308) in its 
kinase-domain activation loop, causing partial activation of Akt/protein kinase B (PKB). However 
the complete activation of Akt requires phosphorylation at serine (473) located in the 
hydrophobic C-terminal domain by mammalian target of rapamycin complex 2 (mTORC2). The 
essential step of GLUT4 translocation to the plasma membrane, is mediated via Akt 
phosphorylation of AS160 (i.e. Akt substrate of 160kD) which is also known as TBC1D4 (i.e. 
member 4 of TBC1 (tre-2/USP6, BUB2, cdc16) domain family). Phosphorylation occurs at T642 
and phospho S/T Akt (PAS) sites, with the (R/K)X(R/K)XXS*/T* recognition motif. 
Phosphorylation of TBC1D4 increases binding to 14-3-3 proteins, which may inhibit Rab-GAP 
function towards downstream Rabs, and promote GTP loading, activation of Rabs and the 
movement of GLUT4 from intracellular compartments to the plasma membrane [20]. 
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Figure 1.1. Regulation of insulin-stimulated glucose uptake. Insulin binds to IR which triggers a cascade 
of phosphorylation events, culminating in the translocation of GLUT4 transporters from the cytoplasm to 
the plasma membrane, which then allow glucose to enter the cell. Adapted from O’Neill [20]. 
 
In addition to its regulatory role in glucose uptake, insulin is also important for 
suppressing lipolysis i.e. the hydrolysis of fats into fatty acids and glycerol, in adipose tissue 
during the fed state. However, in obesity, the impairment of insulin action means that even in 
the fed state free fatty acids (FFA) are released into the circulation [21]. The abnormal 
accumulation of circulating FFA and lipid metabolites such as DAG and ceramides in skeletal 
muscle are postulated to be involved in activating protein kinase C (PKC) α, θ, and ε isoforms 
as well as IκB kinase (IKKβ) and c-Jun N-terminal kinases (JNK). These catalyze the 
phosphorylation of serine/threonine sites of the insulin receptor and substrates IRS1 and IRS2 
(instead of the tyrosine sites), and decrease subsequent phosphorylation of Akt/PKB. The 
remainder of the signaling pathway downstream of these events therefore becomes inhibited, 
leading to reduced or abrogated GLUT4 translocation and glucose uptake [12, 22, 23]. Indeed, 
studies have shown that when rat L6 myotubes are incubated with palmitate, a common 
saturated fatty acid, insulin stimulated glucose uptake and translocation of GLUT4 to the cell 
surface is inhibited, indicating that deposition of fatty acids in insulin target tissues lead to loss 
of insulin sensitivity and cause insulin resistance [17]. This resistance to insulin action, brought 
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on by obesity, is instrumental in the pathogenesis of type 2 diabetes as it induces 
hyperglycemia when compensatory insulin hypersecretion fails. Therefore, from the standpoint 
of adiposity, central fat accumulation, intraorgan lipid deposition and plasma free fatty acid 
accumulation, are all important mediators in the development of insulin resistance and 
metabolic dysfunction [1]. 
 
1.2.2. Inflammation and Adipokine Imbalance 
 
 
Insulin resistance in the obese state is typically accompanied by chronic, low-grade 
inflammation. Exposure to fatty acids induce an inflammatory response in insulin sensitive 
tissues that is characterized by increased generation of reactive oxygen species (ROS), 
activation of mitogen activated protein kinases (MAPK) and nuclear factor-κB (NF-κB), and 
elevations in inflammatory cytokines [17]. Cytokines secreted by adipose tissue are collectively 
called adipokines and metabolic dysfunction that results from excess adipose tissue mass is 
thought to be partly attributable to an imbalance in the expression of pro- and anti-inflammatory 
adipokines, which either induce inflammatory responses and metabolic dysfunction or help to 
resolve inflammation and exert protective effects on obesity-linked metabolic disorders [6].  
 
Most adipokines are pro-inflammatory and are upregulated in obesity, thereby 
exacerbating obesity-linked metabolic and cardiovascular diseases. They include tumour 
necrosis factor (TNF), interleukin-6 (IL-6), resistin, retinol-binding protein 4 (RBP4), lipocalin 2, 
IL-1S, angiopoietin-like protein 2 (ANGPTL2), CC-chemokine ligand 2 (CCL2), CXC-chemokine 
ligand 5 (CXCL5) and nicotinamide phosphoribosyltransferase (NAMPT) [6]. Adipose tissue also 
secretes a smaller number of anti-inflammatory proteins, such as adiponectin and SFRP5. 
Adiponectin is particularly interesting as its expression profile in obesity and states of metabolic 
dysfunction is opposite to the pro-inflammatory adipokines; many rodent and human studies 
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have found that its level decreases with increasing BMI, plasma glucose and insulin, as well as 
serum triglycerides, in spite of an increase in adipose mass [6, 12]. When administered to 
diabetic or obese experimental organisms, it has been shown to protect against several 
metabolic disorders. For example, ob/ob mice given adiponectin demonstrated improvement in 
fatty liver disease through suppression of pro-inflammatory TNFα production [24], 
streptozotocin-induced diabetic mice treated with hydrodynamic injection of adiponectin-
expressing plasmid DNA exhibited a reduction in hyperglycemia brought about by increased 
hepatic glucose uptake [25], and mice fed a high fat/sucrose diet and given adiponectin 
treatment showed increased fatty acid oxidation in muscle tissue and reduced plasma levels of 
glucose, free fatty acids and triglycerides [26]. A more in-depth review of adiponectin and its 
protective effects will be covered in a later section.  
 
 
1.2.3. Skeletal Muscle Myopathies 
 
 
Although the role of obesity in inducing insulin resistance in skeletal muscle has been 
extensively studied, obesity’s part in promoting apoptosis and atrophy in skeletal muscle as well 
as in impairing muscle differentiation and regeneration is also worth consideration [11, 27].   
 
A recent study of the gastrocnemius muscle in diet-induced obese male Wistar rats 
showed that dyslipidemia may be a mechanism for the activation of inflammatory and stress-
activated signaling pathways, which lead to apoptosis and atrophy in skeletal muscle [27]. 
Obese rats demonstrated significant increases in pro-inflammatory TNF-R1 and TNF-R2, which 
contributed to the activation of the NF-κB pathway and the subsequent induction of the E3 
ligase, MuRF-1, which is involved in all models of atrophy. Additionally, physical evidence of 
atrophy in obese rats was also illustrated by a reduction in fibre cross-sectional area in the 
gastrocnemius muscle. Apoptosis was shown to have a role in obesity-related skeletal muscle 
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atrophy as obese animals demonstrated a significant increase in cleaved caspase 3 and PARP 
cleavage downstream of caspase 3 activation [27].    
 
Accumulation of toxic lipid metabolites and inflammation caused by obesity have also 
been found to compromise muscle satellite cell function that results in impaired muscle 
maintenance and regeneration [28]. In vitro studies have found that fatty acids, diacylglycerols 
and ceramides induce apoptosis and reduce myoblast proliferation and differentiation, perhaps 
by activating myostatin, a growth factor that limits the size of muscles [11], and by inhibiting the 
expression or activity of myogenic regulatory factors MyoD and myogenin [13]. Additionally 
ceramides and pro-inflammatory cytokines have been shown to inhibit muscle growth in part by 
inhibiting the IGF-1/Akt /mTOR pathway [29-31]. Hence lipotoxicity arising from obesity might be 
shown to have negative implications for differentiation during muscle regeneration in obese 
animals [11].  
 
1.3. Stress-Activated Cellular Responses Induced by Obesity:  
ER Stress, Autophagy and Apoptosis  
 
As mentioned in section 1.2, excess lipid accumulation brought on by obesity can lead to 
the activation of cellular stress responses [7]. In recent years, the relationships between three of 
these cellular processes, namely, ER stress, autophagy and apoptosis, have come under 
investigation, not only because of their prominent role in obesity but also because they have 
been found to be involved in the development of several other pathologies such as 
neurodegenerative disorders like Alzheimer’s and Parkinson’s, cancer, cardiovascular disease 
and diabetes mellitus [5, 32, 33]. Under conditions of health, each of these processes have 
imperative roles in maintaining cellular homeostasis, but disease states and various adverse 
stimuli such as DNA damage, pathogens, hypoxia, hyperglycemia and lipotoxicity, can cause 
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their dysregulation and induce stress signaling pathways that often involve cross talk between 
them [5, 32-35].  
 
1.3.1. ER stress  
 
 
1.3.1.1. Function and Signaling Pathway 
 
 
In the eukaryotic cell, the endoplasmic reticulum (ER) organelle has important roles in 
protein and lipid biosynthesis, folding of newly synthesized peptides, modification of secreted 
proteins, detoxification of xenobiotics and the maintenance of calcium homeostasis [36, 37]. It 
efficiently processes approximately one third of all proteins produced, but when the amount of 
nascent proteins exceeds its processing capacity, unfolded or misfolded proteins accumulate 
and disrupt ER homeostasis causing ER stress [36]. This usually results from various 
physiological and pathological insults including high protein demand, viral infections, 
environmental toxins, inflammatory cytokines and mutant protein expression [38]. The unfolded 
protein response (UPR) is then activated as a cellular self-defense mechanism that reduces ER 
stress by reducing protein synthesis, increasing protein folding and increasing the degradation 
of misfolded proteins [39].  
 
These actions are mediated by three ER transmembrane proteins, namely, double 
stranded RNA-dependent protein kinase-like ER kinase (PERK), inositol-requiring enzyme-1 
(IRE1), and activating transcription factor 6 (ATF6). When glucose-regulated protein (GRP78), 
an ER chaperone, becomes dissociated from these proteins’ luminal domains, due to 
recruitment for protein folding, the UPR is triggered [40].  
 
The first response to lessen ER stress is a reduction in protein translation and ER 
workload, mediated by PERK. PERK becomes homodimerized and autophosphorylated, and 
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then phosphorylates the α subunit of eukaryotic translation initiation factor 2 (eIF2), which 
reduces global protein synthesis and translation. The expression of transcription factor ATF4 is 
increased and genes involved in antioxidant response and amino acid transport are induced. 
Finally PERK activation may lead to the expression of pro-apoptotic transcription factor 
CCAAT/enhancer-binding protein (C/EBP) homologous protein (CHOP) and induction of 
Gadd34 (growth arrest and DNA damage-inducible protein 34), which results in negative 
feedback of eIF2α phosphorylation and attenuation of PERK signaling [7, 40, 41].  
 
The second pathway of the UPR involves IRE1 which also becomes homodimerized and 
autophosphorylated, and cleaves the X-box binding protein 1 (XBP1) mRNA. The spliced form 
of XBP1 is translated and translocated to the nucleus, where it initiates several transcriptional 
programs involved in protein folding, maturation and degradation [7, 41]. 
 
The third pathway of the UPR takes effect when the basic leucine zipper domain protein 
ATF6 is activated, and becomes translocated to the Golgi. It is cleaved by site 1 and site 2 
proteases, releasing its N-terminal cytosolic domain, which then enters the nucleus and 
regulates ER chaperone expression, induces XBP1 expression, and increases induction of ER-
associated degradation (ERAD) proteins by forming a heterodimer with spliced XBP1 [7, 40, 
41].  
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Figure 1.2. ER stress and activation of the UPR pathways. In response to ER stress, GRP78 becomes 
dissociated from the luminal domains of PERK, IRE1 and ATF6 and triggers the UPR, which induces a 
transcriptional program focused on re-establishing homeostasis. Taken from Basseri & Austin [40].  
 
 
1.3.1.2. Role in the Complications of Obesity 
 
 
Many studies have investigated the role of ER stress in the pathogenesis of obesity and 
there are many lines of thought regarding the potential pathways and mechanisms that might be 
involved. For example, all three branches of the UPR have been shown to induce inflammation, 
which is a key marker of obesity, through activation of NF-κB  and/or JNK signaling. Specifically, 
when PERK is activated and protein translation is reduced, IKB levels become reduced as well, 
as does the inhibition of NF-κB  activity. The cytosolic domain of IRE1α can associate with TNF 
receptor–associated factor 2 (TRAF2) to activate the JNK pathway, and by interacting with the 
adaptor protein Nck (noncatalytic region of tyrosine kinase) and a protein complex composed of 
IKK and TRAF2, it can activate the NF-κB  pathway. A link between ATF6 and the activation of 
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NF-κB  has also been demonstrated as when ATF6 is genetically and pharmacologically 
inhibited, NF-κB  activation has been found to be suppressed [7].  
 
In addition, in-vitro models of lipotoxicity induced by palmitate in various cell types, have 
shown that it increases ER stress by several mechanisms. In pancreatic β-cells palmitate 
disrupts the calcium homeostasis in the ER by causing calcium efflux [42]. In mouse insulinoma 
cell line MIN6 it significantly reduced the rate of ER-to-Golgi protein trafficking, thereby 
contributing to impaired protein exit and increased protein overload [43], in H9c2 cells palmitate 
increased protein aggregation, phosphorylation of PERK and eIF2α, and caused abnormal 
extension and swelling of the rough endoplasmic reticulum [44], and in HepG2 cells palmitate 
treatment significantly increased levels of XBP1mRNA splicing and CHOP expression, in 
addition to activating JNK and decreasing Akt phosphorylation, suggesting that ER stress-
mediated JNK activation may be involved in insulin resistance in the liver [45]. 
 
Similarly, studies in skeletal muscle using high-fat diet or palmitate have been shown to 
activate the UPR. Mice fed a diet containing 70% fat and <1% carbohydrates for 6 weeks 
demonstrated higher levels of UPR markers BiP and IRE1 alpha in the soleus and in the tibialis 
anterior muscles, and mice fed a diet containing 46% fat and 36% carbohydrates for 20 weeks 
also showed more GRP78, IRE1 alpha, phospho-PERK, CHOP, and both spliced and unspliced 
forms of XBP1 in the plantar flexors[46]. The mediation of insulin resistance by palmitate-
induced ER stress was also demonstrated in skeletal muscle. When treated with palmitate, L6 
myotubes showed increased phosphorylation of UPR proteins PERK and eIF2α, and decreased 
insulin-stimulated phosphorylation of Akt (Ser473) [47].  
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1.3.2. Autophagy  
 
 
1.3.2.1. Function and Mechanisms 
 
 
Autophagy is a general term for the evolutionarily conserved catabolic process that 
captures cytoplasmic components for lysosomal degradation [48]. Three types of autophagy 
have been characterized: 1) macroautophagy which involves the formation of a double-
membraned vesicle called the autophagosome, 2) chaperone-mediated autophagy which 
involves the binding of proteins containing a KFERQ motif to a chaperone protein for 
translocation to the lysosomes, where it binds to lysosome-associated membrane protein type 
2A (LAMP-2A) receptor and is subsequently internalized and degraded, and 3) microautophagy 
which involves the direct sequestration of cellular components by the lysosome through the 
invagination of the lysosomal membrane [5]. Mizushima [48] notes however, that unless 
specifically indicated, the general use of the term “autophagy” typically refers to 
macroautophagy, and it is this process that is investigated in this thesis.  
 
Autophagy has been called a “double-edged sword” [49] as it can either be beneficial or 
detrimental to the cell, depending on the context. On one hand, basal autophagy is essential for 
maintaining cellular homeostasis and for the turnover of cytosolic components, as it degrades 
long-lived proteins, defective organelles and intracellular pathogens, thereby protecting the cell 
and replenishing it with molecules for future anabolic purposes [5, 48]. Additionally, when faced 
with nutrient starvation, cells use autophagy as a stress adaptation that circumvents cell death 
by enabling adaptive protein synthesis from degraded macromolecules [50]. Autophagy has 
also been implicated in providing protection against aging and pathologies such as cancer, 
neurodegeneration and cardiac disease [5]. However, on the other hand, prolonged or 
excessive autophagy can result in an alternative pathway to cell death, called autophagic or 
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type II cell death [50], that arises when the autophagic process catabolizes excess cytoplasm 
and indispensable cell components [51].  
 
Autophagy consists of distinct stages, each of which is facilitated by numerous proteins. 
The process is initiated with the formation of a small vesicular sac in the cytoplasm called the 
isolation membrane or phagophore, that then encloses a portion of cytoplasm containing 
targeted organelles, proteins etc. to form the characteristic double-membraned autophagosome 
[5]. Though the origin of the autophagosomal membrane is undecided, possible sources include 
the endoplasmic reticulum (ER), mitochondria, golgi and plasma membrane [52]. This is 
followed by the fusion of the autophagosome with a lysosome, creating the autophagolysosome, 
that then leads to the degradation of the sequestered cellular constituents by lysosomal 
enzymes, and the release of amino acids and other compounds into the cytoplasm for recycling 
or energy production [5].  
  
Autophagosome formation utilizes 18 different Atg proteins and is comprised of three 
major steps: initiation, nucleation and elongation/enclosure [5]. The initiation step is controlled 
by the ULK1 (UNC-51-like kinase 1)–FIP200 (FAK family kinase-interacting protein of 200 kDa) 
ATG13 ATG101 complex. The serine/threonine kinase mammalian target of rapamycin (mTOR), 
interacts with and inactivates ULK1 by phosphorylation. Under starvation conditions, autophagy 
is induced via the inactivation of mTOR that results in ULK1 activation and phosphorylation of 
Atg13 and FIP200. The nucleation step involves the lipid kinase vacuolar protein sorting 34 
(VPS34)-Beclin 1-class III phosphatidylinositol 3-kinase (PI3K) complex that also includes 
Vps15, Atg14L and Ambra-1. This complex is usually inactivated by anti-apoptotic proteins from 
the BCL-2 family, but when it is active it enables the nucleation of the isolation membrane. The 
final elongation and enclosure step requires the recruitment of two ubiquitin-like protein 
conjugation systems. Firstly, the conjugation of Atg12–Atg5 is mediated by ligases Atg7 and 
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Atg10. Atg5 also associates with Atg16 to form the Atg12–Atg5–Atg16 complex. Second, the 
microtubule-associated protein light chain 3 (LC3) which is the mammalian homolog of yeast 
Atg8 is cleaved at its carboxyl terminus by Atg4, giving rise to the soluble, cytosolic form LC3-I, 
which is then conjugated to phosphatidylethanolamine (PE) through the action of Atg7 and Atg3. 
This lipid conjugated form, LC3-II, is localized to the autophagosomal membrane, and allows 
the closure of the autophagic vacuole [5, 51]. LC3 is to date the only protein that has been 
identified on the inner membrane of the autophagosome and hence is the most commonly used 
protein marker for autophagic vacuoles, with an increase in LC3II showing an increase in 
autophagsome formation [48].  
 
Another protein important in the assessment of autophagy is p62, which delivers 
ubiquitinated proteins to the autophagosome for degradation by binding to the polyubiquitin 
chains and LC3 [53]. p62 is then preferentially degraded by autophagy [48]. Autophagic flux is 
said to increase when LC3-II levels increase and p62 levels show a corresponding decrease. 
Two additional proteins which participate in the recruitment of molecules to the isolation 
membrane are the transmembrane proteins, ATG9 and vacuole membrane protein 1 (VMP1), 
which recycle between the golgi, endosomes and autophagosomes, probably shuttling lipids for 
degradation [51]. The next stage of autophagy, the fusion between autophagosomes and 
lysosomes is believed to be mediated by several SNARE-like proteins, and finally, in the 
autolysosome, various lysosomal enzymes hydrolyse proteins, lipids and nucleic acids [51].   
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Figure 1.3. The major stages of autophagy. (a) The initiation step of autophagsome formation is 
controlled by the ULK1-FIP200-ATG13-ATG101 complex, and inhibited by mTOR. (b) The nucleation 
step involvesVPS34-Beclin 1-class III PI3K complex, which is inactivated by anti-apoptotic BCL-2 family 
proteins. (c) Transmembrane proteins ATG9 and VMP1 recruit molecules to the isolation membrane. (d) 
The elongation and enclosure step of autophagosome formation requires two ubiquitin-like protein 
conjugation systems. Firstly, the conjugation of Atg12–Atg5 is mediated by ligases Atg7 and Atg10. Atg5 
also associates with Atg16 to form the Atg12–Atg5–Atg16 complex. Second, LC3 is cleaved by Atg4 to 
form LC3-I, which then undergoes lipid conjugation through the action of Atg7 and Atg3 to form LC3-II, 
which is then localized to the autophagosomal membrane. (e) Fusion between autophagosomes and 
lysosomes is mediated by SNARE-like proteins. (f) Various lysosomal enzymes hydrolyse proteins, lipids 
and nucleic acids in the autolysosome. Taken from Marino et al [51]. 
 
1.3.2.2. Role in the Complications of Obesity 
 
 
Obesity has been known to inhibit effective autophagy by activating anti-autophagic Akt 
and mTOR signaling pathways and down-regulating autophagic genes such 
as Ulk1/Atg1, Atg5, Atg7, and Atg6/Beclin1 [54]. This defective autophagy is capable of 
promoting obesity-related inflammation through several mechanisms including p62 
accumulation that leads to TRAF6 oligomerization and NF-κB activation [55], and impaired 
autophagy of damaged mitochondria, i.e. mitophagy, that upregulates reactive oxygen species 
and inflammasome activation [56].   
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In addition, recent studies have demonstrated autophagy’s importance in whole-body 
lipid and glucose homeostasis [5, 57]. In this way, autophagy’s roles in the pathogenesis of 
obesity, in which such homeostasis is disrupted, has come under investigation. For example, 
Singh et al [58] have shown that when lipid availability is moderately increased, hepatic 
autophagy facilitates lipophagy i.e. the degradation of lipid droplets to provide free fatty acids for 
ATP production, in this way regulating lipid content and metabolism, and providing a mechanism 
for the prevention of steatosis. The movement of lipids through the autophagic pathway was 
evidenced by fluorescence and electron microscopy of hepatocytes that showed co-localization 
of lipids with autophagosomes and lysosomes, and immunogold staining which demonstrated 
that LC3 associated with lipid droplets. Additionally, when autophagy was inhibited by genetic 
knockdown of Atg5 or pharmacological treatment with 3-methyladenine, RALA255-10G 
hepatocytes treated with oleic acid for between 2 to 8 hours showed significantly 
increasedcellular triglyceride content. The impairment of autophagy resulted in decreased 
lipolysis and fatty acid β-oxidation, and excessive retention of triglycerides and cholesterol in 
lipid droplets [58].  
 
However the same authors also reported that lipophagy was unable to cope with 
abnormal, sustained availability of lipids. Mice were fed a high-fat diet for 16 weeks (34g per 
100g diet fat, 0.03g per 100g diet cholesterol with 60% of the total kcal in fat), and electron 
microscopy of their liver tissue demonstrated a reduced association of autophagic vacuoles with 
lipid droplets in response to starvation [58]. This reduction in the efficiency of interaction 
between the autophagic system and lipid droplets may be due to the alteration of membrane 
structure by lipid accumulation, that decreases fusion efficiency between autophagosomes and 
lysosomes [5]. 
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 Other studies have shown that a deficiency in autophagy could lead to insulin resistance 
that is a core component of metabolic disorders brought on by obesity such as type 2 diabetes. 
Ebato et al [59] have reported that in the pancreas, basal autophagy is important for maintaining 
normal islet architecture and function. They found that mice deficient for Atg7, demonstrated 
degeneration of islets, substantial beta cell death and diminished beta cell mass. This translated 
to impaired glucose tolerance and insulin secretion when these mice were challenged with high-
fat diet. On the other hand, INS-1 beta cells, treated with the FFA oleate, and the beta cells of 
diabetic db/db and high-fat-fed C57BL/6 mice showed increased induction of autophagy, 
thereby suggesting that inductive autophagy might be an adaptive response of beta cells to 
increased insulin resistance in obesity [59].  
 
1.3.3. Apoptosis  
 
 
1.3.3.1. Function and Regulatory Mechanisms 
 
 
Apoptosis is a highly regulated type of programmed cell death or cell suicide 
characterized by morphological changes, including nuclear condensation (pyknosis), 
fragmentation (karyorrhexis) and plasma membrane blebbing [60]. It is important in multicellular 
organisms for various processes such as normal cell turnover, proper development and 
functioning of the immune system, hormone-dependent atrophy, embryonic development and 
chemical-induced cell death [61, 62].  
 
During the process of apoptosis, the cell shrinks, cytoplasm becomes dense, organelles 
become more tightly packed, and chromatin condenses. Extensive plasma membrane blebbing 
is followed by nuclear fragmentation and the separation of the cell components into apoptotic 
bodies that consist of cytoplasm with tightly packed organelles with or without a nuclear 
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fragment. Macrophages, parenchymal cells, or neoplastic cells then phagocytose these 
apoptotic bodies and degrade them within phagolysosomes [62].  
 
There are two main pathways in the cell for the initiation of apoptosis: 1) the extrinsic 
death-receptor pathway, and 2) the intrinsic mitochondrial pathway [51]. The extrinsic pathway 
utilizes transmembrane receptors that contain a cytoplasmic domain of about 80 amino acids 
termed the “death domain”, which is responsible for transmitting the death signal from the cell 
surface to intracellular signaling pathways. Some of the ligands and corresponding death 
receptors identified to date are FasL/FasR, TNF-α/TNFR1, Apo3L/DR3, Apo2L/DR4 and 
Apo2L/DR5, among which the FasL/FasR and TNF-α/TNFR1 models have the best 
characterized signaling cascades. First, ligands bind with the death receptors, leading to the 
recruitment of adapter proteins that exhibit corresponding death domains. Specifically, the 
binding of Fas ligand to Fas receptor results in the binding of the adapter protein FADD, and the 
binding of TNF ligand to TNF receptor results in the binding of the adapter protein TRADD with 
subsequent recruitment of proteins FADD and RIP. FADD then associates with procaspase-8, 
leading to caspase 8 dimerization and activation [51]. Once active, caspase 8, an “initiator 
caspase” [61], can directly cleave and activate “effector or executioner caspases” caspase 3 
and caspase 7 [60, 63], leading to caspase-dependent apoptosis. There is potential for cross 
talk here with the intrinsic apoptotic pathway, as activated caspase 8 can also truncate the BH3-
only protein BID (BH3-interacting domain death agonist), which translocates to the mitochondria 
and causes organelle damage [51]. 
 
The intrinsic pathway of apoptosis is characterized by one central injurious event – 
mitochondrial outer membrane permeabilization (MOMP) [51]. Non-receptor-mediated stimuli 
activate B cell lymphoma 2 (Bcl-2) homology 3 (BH3)-only proteins, which stimulate MOMP by 
inducing the oligomerization of BCL-2-associated X protein (BAX) and/or BCL-2 antagonist or 
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killer (BAK) in the outer mitochondrial membrane. This forms supramolecular channels that 
enable the release of two groups of soluble proapoptotic proteins from the mitochondrial 
intermembrane space into the cytosol. Among the first group is cytochrome c that binds 
apoptotic protease-activating factor 1 (APAF1), inducing its oligomerization and forming a 
structure called the apoptosome that recruits and activates “initiator caspase”, caspase 9. 
Caspase 9 cleaves and activates “effector or executioner caspases”, caspase 3 and caspase 7, 
leading to caspase-dependent apoptosis. In addition, second mitochondria-derived activator of 
caspase (SMAC/DIABLO) and OMI are also released from the mitochondria to promote 
apoptosis by neutralizing the caspase inhibitory function of X-linked inhibitor of apoptosis protein 
(XIAP) [51, 62]. The second group of proapoptotic proteins are released from the mitochondria 
later in the timeline of apoptosis, after the cell has committed itself to death, and function in a 
caspase-independent manner. This group consist of apoptosis-inducing factor (AIF) and 
endonuclease G (EndoG) which translocate to the nucleus, to cause DNA fragmentation and 
condensation of chromatin [62]. PUMA and NOXA are two other BCL2 family members that 
have been shown to have proapoptotic roles. Overexpression of PUMA in vitro was 
demonstrated to be accompanied by increased BAX expression, BAX conformational change, 
translocation to the mitochondria, cytochrome c release and reduction in mitochondrial 
membrane potential [64], while NOXA has been shown to localize to the mitochondria, interact 
with anti-apoptotic Bcl-2 family members, and thereby activate caspase 9 [65]. 
 
 The extrinsic and intrinsic apoptotic pathways converge on the “execution pathway” that 
constitutes the final phase of apoptosis [62]. This pathway is initiated by activation of the 
“execution or effector caspases”, caspase 3, caspase 6 and caspase 7, and results in DNA 
fragmentation, degradation of cytoskeletal and nuclear proteins, cross-linking of proteins, 
formation of apoptotic bodies, expression of ligands for phagocytic cell receptors and finally 
uptake by phagocytic cells [62]. 
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Figure 1.4. The two main pathways for the initiation of apoptosis (a) the extrinsic death-receptor pathway, 
and (b) the intrinsic mitochondrial pathway. Taken from Marino et al [51]. 
 
 
1.3.3.2. Role in the Complications of Obesity 
 
 
Lipoapoptosis, a type of programmed cell death induced specifically by lipid overload in 
conditions of obesity, has been described in many studies. When fatty acid (FA) influx into non-
adipose cells chronically exceeds oxidative capacity, the FA surplus is forced to enter available 
pathways of nonoxidative metabolism. Initially, they may be esterified to relatively harmless 
triacylglycerols (TG) but ultimately, hydrolysis of these TG stores will only lead to exacerbated 
accumulation of fatty acyl CoA, providing additional substrate for other lipotoxic nonoxidative FA 
metabolic pathways [66].  
 
De novo ceramide biosynthesis, which involves the condensation of palmitate and 
serine, is the best characterized of these. Ceramide causes apoptosis by activating NFκB which 
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increases the expression of inducible nitric oxide synthase (iNOS) and increases the formation 
of nitric oxide (NO). Alternatively, ceramide may decrease Akt phosphorylation, thereby 
preventing its inactivation of pro-apoptotic BCL2 family members Bad, Bax, Bid and Bim. In 
addition ceramide has also been shown to inhibit mitochondrial respiratory chain complexes I 
and III, causing harmful mitochondrial alterations [67]. The apoptotic effect of ceramide has 
been demonstrated in various cell types, such as pancreatic beta cells [68], cardiomyocytes 
[69], hepatocytes [70] and skeletal muscle [71]. 
 
The consequences of lipoapoptosis in the heart can lead to heart failure as was 
illustrated by a study that utilized cardiomyocyte-specific acyl CoA synthase (ACS)-
overexpressing mice [72]. ACS-overexpression increased fatty acid transport across the plasma 
membrane of cardiomyocytes, and led to elevated levels of cardiac TG and ceramide, as well as 
cytosolic cytochrome-c release from mitochondria. The mice exhibited initial cardiac 
hypertrophy, followed by the development of left-ventricular dysfunction and premature death 
[72].  
 
In insulin-sensitive tissues, such as skeletal muscle and adipocytes, lipoapoptosis was 
implicated in the inhibition of insulin-stimulated glucose utilization. In L6 myotubes, palmitate 
increased apoptosis and decreased glucose uptake, but the addition of effector caspase 
inhibitors [Ac-DEVD-aldehyde (DEVD-CHO), Z-DQMD-FMK] restored >80% of insulin-
stimulated glucose uptake [71]. In3T3-L1 adipocytes, ceramide was found to decrease insulin-
stimulated glucose uptake by decreasing GLUT4 translocation, through the inhibition of Akt 
activity [73].   
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1.4. Cross talk and Links Between ER Stress, Autophagy and Apoptosis 
 
 
1.4.1. ER Stress Induces Autophagy as a Rescue Mechanism 
 
 
When the cell experiences ER stress, it activates a number of pathways to help alleviate 
protein overload and restore homeostasis. As previously described, the UPR is the chief cellular 
response that acts to down regulate protein synthesis and up regulate protein folding and 
degradation [39]. However, it has been proposed that autophagy is another mechanism that 
may also be induced to help cells cope with ER stress by contributing to the elimination of 
unfolded or aggregated proteins [74]. Indeed, ER stress can stimulate the assembly of 
autophagosomes. Polyglutamine- and drug-induced ER stress has been found to facilitate the 
conversion of LC3I to LC3II, a key step for autophagosome formation [75], and in yeast atg11Δ 
cells that have an inherent defect in pre-autophagosomal structure (PAS) assembly, it was 
found that induction of ER stress by tunicamycin facilitated PAS formation, as observed by 
following the localization of GFP-Atg8 (yeast homolog of LC3) with autophagic vesicles [76].  
 
Additionally, Ogata et al [39] found that treating SK-N-SH neuroblastoma cells with ER 
stressors tunicamycin and thapsigargin markedly induced the formation of autophagosomes, 
which were recognizable by the formation of green fluorescent protein (GFP)-LC3-labeled 
puncta, that represented the autophagosomal conversion of LC3I of LC3II. The group reported 
that the IRE1-JNK pathway appeared to be involved in the activation of autophagy following ER 
stress as they found that autophagy was inhibited in IRE1-deficient MEF cells or cells treated 
with JNK inhibitor SP600125 [39]. Evidence has also been provided to show that PERK-eIF2-
dependent Atg12 upregulation is required for induction of autophagy in response to 
polyglutamine protein accumulation. When a dominant-negative form of PERK was utilized or 
phosphorylation of eIF2 was prevented by genetic substitution of its Serine 51 with Ala, 
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polyglutamine protein-induced autophagy was inhibited. This suggested that controlling the 
expression of autophagy-related genes by eIF2 downstream targets could be one of the 
mechanisms connecting both the UPR and autophagy [74, 75]. Additionally H9c2 cells treated 
with palmitate alone demonstrated more autophagic flux, evidenced by LC3 and p62 
expression, than cells treated additionally with salubrinal, an ER stress inhibitor [44]. Therefore 
autophagic flux may indeed be mediated by ER stress.    
 
1.4.2. Prolonged or Excessive ER Stress Induces Apoptosis 
 
Though pro-apoptotic outputs like CHOP production occur as a result of UPR signaling, 
activation of the UPR is generally accepted as being a primarily adaptive and prosurvival 
response of the cell to try to manage ER stress. Indeed, the combined actions of the IRE1α, 
PERK, and ATF6α pathways are predominantly initially protective as they collectively work to 
reduce translation, enhance ER protein-folding capacity and clear misfolded ER proteins [35]. 
Rutkowski et al [77] proposed that the preliminary outweighing of proapoptotic factors by 
prosurvival factors may be partially due to the greater stability of prosurvival UPR effector 
molecules like GRP78 at both the mRNA and protein levels [77]. Hence the cell initially attempts 
to adapt to ER stress and regain homeostasis by increasing chaperone levels to facilitate 
protein folding or increasing protein degradation to get rid of terminally misfolded proteins. 
However if these measures are not successful at assuaging ER stress, and ER stress becomes 
prolonged or excessive, as would happen in cases where lethal ER toxins are present or when 
production of terminally misfolded proteins persists, protective outputs would diminish. 
Proapoptotic UPR signaling would then proceed unchecked, and the cell might also be left 
vulnerable to other damaging stimuli like hypoxia and nutrient starvation, ultimately leading to 
cell death via apoptosis [35]. 
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Many studies have investigated CHOP’s role in mediating ER-stress induced apoptosis. 
Several genes have been found to be induced in CHOP’s transcriptional program including 
GADD34 and ERO1. GADD34, a regulatory subunit of protein phosphatase 1 (PP1) targets PP1 
to dephoshorylate eIF2, which then enables protein synthesis to start up again. If the protein 
folding capacity of the stressed ER has not yet been restored, such a de-inhibition of translation 
will only act to intensify ER stress by exacerbating ER protein load and improper disulphide 
bond formation of unfolded proteins [78]. Increased expression of ERO1 by CHOP causes 
hyperoxidizing conditions in the ER which also expedites apoptosis via oxidative stress [79, 80]. 
CHOP has also been found to regulate the expression of some Bcl-2 family proteins that 
govern mitochondrial outer membrane permeabilization (MOMP). Though the mechanism is 
unknown, CHOP appears to suppress the expression of antiapoptotic Bcl-2, while promoting the 
transcription of proapoptotic BH3-only protein Bim [74]. Puma and Noxa are other proapoptotic 
BH3 family proteins that are transcriptionally regulated by ER stress. They are called sensitizers 
of apoptosis as they interact with various anti-apoptotic proteins, inhibiting their effects and 
inducing MOMP [81].  
 
Among the three branches of the UPR, PERK signaling which involves the induction of 
CHOP, is generally agreed upon to have proapoptotic effects. Indeed, Lin et al [82] 
demonstrated that sustained PERK signaling impaired cell proliferation and promoted apoptosis. 
However the effects of the IRE1 and ATF6 pathways appear to be more ambiguous. ATF6 
signaling has been stated to be largely prosurvival and adaptive, however by its ability to 
upregulate CHOP during prolonged ER stress, it can also be pro-apoptotic [81]. IRE1 signaling 
has been regarded as an adaptive response that occurs early in the UPR and diminishes with 
prolonged ER stress [83], but it has also been postulated to have a role in proapoptotic 
pathways via the IRE1a-TRAF2-JNK axis which plays parts in upregulating the proapoptotic 
activity of Bid and Bim (i.e. other Bcl-2 family proteins) and in modulating TNFa release that 
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activates death receptor signaling [81].  
 
1.4.3. Interplay Between Autophagy and Apoptosis 
 
 
1.4.3.1. Autophagy Precedes and Inhibits Apoptosis 
 
 
There are many links between autophagy and apoptosis, and crosstalk is often 
observed. This is because many stimuli that ultimately cause apoptosis also initiate autophagy 
which, as previously described, often precedes apoptosis as one of the cellular mechanisms 
attempting to adapt to and cope with stress. Therefore, in general, autophagy is believed to 
protect against the induction of apoptosis [45].  
 
When agents inducing cellular stress cause mitochondrial damage and MOMP, 
proapoptotic factors are released into the cytoplasm, including catabolic hydrolases such as 
apoptosis inducing factor (AIF) or endonuclease G (EndoG), and caspase activators such as 
cytochrome c and SMAC (second mitochondria-derived activator of caspase) [84]. Release of 
these proapoptotic factors may be reduced via activation of mitophagy i.e. the specific 
autophagic elimination of damaged mitochondria. This is accomplished via the dissipation of the 
inner mitochondrial transmembrane potential that occurs during MOMP and leads to the 
inhibition of PINK1 (PTEN-induced putative kinase 1) proteolysis. PINK1 then accumulates at 
the surface of damaged mitochondria and recruits the E3 ubiquitin ligase PARKIN (Parkinson’s 
disease protein) to ubiquitinate proteins in the outer mitochondrial membrane, thereby targeting 
the mitochondria for degradation [85]. Mitophagy of damaged, apoptosis-inducing mitochondria 
can therefore delay the onset of apoptosis, by increasing the threshold for apoptosis induction 
[51]. In addition, autophagy has been shown to selectively target specific proapoptotic proteins 
in the cytoplasm such as active caspase 8 [86]. These proteins are ubiquitinated, which 
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facilitates their interaction with selective autophagy receptors, such as p62, that also binds LC3. 
In this way targeted proteins are selectively brought to the autophagosome for degradation [87]. 
 
1.4.3.2. Apoptosis Inhibits Autophagy beyond a Critical Threshold of Stress 
 
If the intensity or duration of stress surpasses a cell’s ability to cope, adaptive 
mechanisms including autophagy are overtaken by apoptosis. Furthermore, once apoptosis is 
initiated caspase activity acts to inactivate the autophagic pathway and shut down its 
cytoprotective function, in order to further enhance cell death [51]. This can occur through 
caspase-mediated digestion of several essential autophagy proteins, such as ATG3 [88], Beclin 
1[89, 90] and AMBRA1 (activating molecule in BECN1-regulated autophagy 1) [91]. Additionally, 
studies have found that autophagy protein fragments leftover from caspase cleavage may 
acquire pro-apoptotic functions. For example, when caspase 3, caspase 6 or caspase 9 cleaved 
Beclin 1 in Ba/F3 cells, a carboxy-terminal fragment was produced that localized to 
mitochondria, causing permeabilization and the release of cytochrome c [89]. 
 
1.4.3.3. Autophagy Induces Cell Death via Apoptosis, Independent of Autophagic 
Cell Death  
 
 
Though autophagy is recognized as a cytoprotective mechanism, there are certain cases 
in which it might lead to cell death. One of these is the previously described autophagic cell 
death (ACD), which occurs when extreme autophagy degrades the cytoplasm excessively and 
catabolizes indispensable portions of cells [51]. It is important to note, as indicated in a recent 
review by Marino et al [51], that strictly speaking, the term ACD should refer to cell death 
specifically caused by increased autophagic flux, rather than by apoptosis or necroptosis. It 
should not be confused with cell death simply accompanied by autophagy. Also, the authors 
note that ACD will be circumvented when autophagy is inhibited [51]. However, there is some 
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disparity in the field regarding what constitutes ACD, as Kroemer and Levine [92] point out that 
the term has simply been used to describe cell death with autophagy.  
 
Regardless, beyond ACD, research has shown that autophagosomes or autophagic 
proteins, rather than the autophagic degradative process, are capable of inducing true apoptosis 
[51]. Autophagsomes may serve as a platform for the activation of caspase 8, through the 
formation of an intracellular death-inducing signaling complex composed of caspase 8, FADD 
and ATG5, that colocalizes with LC3 and p62 [93]. ATG12 has been shown to interact with anti-
apoptotic BCL-2 family members, via stimulation by proapoptotic stressors such as C6 ceramide 
or tunicamycin, thereby inhibiting their function and enhancing mitochondrial apoptosis [94]. In 
addition, ATG7 has been shown to induce intrinsic apoptosis following lysosomal photodamage 
by causing lysosomal membrane permeabilization [95], that may trigger MOMP through the 
release of cathepsin proteases into the cytosol [51]. 
 
1.4.3.4. Autophagy Protects Against ER Stress-Induced Apoptosis 
 
 
As discussed in Section 1.4.1., autophagy may be activated as an adaptive response to 
alleviate ER stress, and many studies have in fact demonstrated autophagy’s ability to inhibit 
apoptosis induced by ER stress. For example, ATG5 wild type and ATG5-deficient MEF cells 
exposed to tunicamycin, a stimulator of ER stress, exhibited ER-stress dependent caspase 3 
activation and cell death, which was augmented in the autophagy-impaired ATG5-deficient 
group [39]. In H9c2 cells co-treated with palmitate and bafilomycin, an inhibitor of autophagy, 
the extent of cell death was analyzed via Annexin V and caspase-3 expression. It was found to 
be increased when palmitate-induced autophagy was inhibited by bafilomycin treatment [44]. 
[better to rework this sentence and simplify] Exacerbation of cellular damage imposed by ER 
stress through the obstruction of autophagy was also demonstrated in SK-N-SH cells that 
exhibited marked chromatin condensation and fragmentation when treated with tunicamycin in 
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the presence of 3-MA, another inhibitor of autophagy [39]. Conversely, using rapamycin to 
induce autophagy through inhibition of mTOR function, has been shown to make H9c2 cells [44] 
and HeLa cells [39] more resistant to ER stress-induced cell death. Additionally, beta-cell 
apoptosis caused by ER stress arising from accumulation of misfolded proinsulin in diabetic 
Akita mice with a mutation in proinsulin, was reduced when they were treated with rapamycin 
[96]. All these reports therefore support the idea that autophagy is a cellular self-protective 
mechanism against ER-stress induced apoptosis [44].   
 
 
1.5. Adiponectin  
 
1.5.1. Structure  
 
Adiponectin (also known as ACRP30 and ADIPOQ) is a 30kD protein that is primarily 
secreted by adipocytes and is highly abundant in the blood, occurring at levels of approximately 
3-30ug/ml. It consists of an amino-terminal signal sequence followed by a collagen-like domain 
and a carboxyl-terminal globular domain. The monomers can form trimers (low molecular weight 
i.e. LMW form), hexamers (medium molecular weight i.e. MMW form) and oligomers (high 
molecular weight i.e. HMW form). The mixture of these different oligomeric forms circulating in 
the plasma is termed full length adiponectin (fAd), but an additional form, globular adiponectin 
(gAd) containing only the carboxyl-terminal, may be generated by the enzymatic cleavage of 
adiponectin [6, 97, 98].  
 
 
1.5.2. Role in the Complications of Obesity and Functional Significance 
 
The level of circulating adiponectin has an inverse relationship with BMI, plasma glucose 
and insulin, and serum triglycerides, in spite of an increase in adipose mass [6, 12]. Many 
studies have recognized the central role that the reduction of adiponectin action has in 
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metabolic syndrome and obesity-related diseases, as decreased plasma adiponectin levels 
have been associated with type 2 diabetes [99], dyslipidemia [100], cardiovascular disease 
[101], hypertension [102], cancer [103] and non-alcoholic steatohepatitis [104]. Two 
mechanisms have been proposed for impaired adiponectin effects in such disease conditions; 
the first is the absolute decrease of circulating adiponectin and the other is decreased 
adiponectin sensitivity, both of which may be caused in part by obesity-related increases in 
oxidative stress and inflammation [105].  
 
Though adiponectin action is naturally impaired in many metabolic disease states, 
research has shown that increasing adiponectin effects is possible through various strategies 
such as the exogenous administration of adiponectin through injection or in vitro treatment, the 
increase of adiponectin expression using compounds like TZDs, the activation of AdipoRs using 
small molecule compounds and antibodies, and the increase of AdipoR expression levels such 
as by implementing PPARα activation by its agonist Wy-14,643 [105]. Indeed, upregulating 
adiponectin action has been demonstrated to confer protective effects through its antidiabetic, 
insulin-mimetic, insulin-sensitizing, anti-inflammatory and anti-atherosclerotic properties [106-
108].  
 
An example of this is the study done by Yamauchi et al [109] that used KKAy mice (KK 
mice overexpressing the agouti protein), as a model of the metabolic syndrome and obesity-
related type 2 diabetes. It was found that plasma adiponectin levels were decreased in these 
mice when fed a high-fat diet (HFD), and insulin resistance was pronounced. However glucose 
tolerance test results obtained after replenishment of adiponectin showed a significant 
amelioration in hyperglycemia and hyperinsulinemia, providing evidence of adiponectin’s insulin-
sensitizing and anti-diabetic actions [109]. 
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More recent work has shown that adiponectin’s ability to combat insulin resistance may 
occur in part due to its stimulation of autophagy and antioxidant potential. Liu et al [110] found 
that adiponectin treatment not only reduced oxidative stress, but also reinstated high-fat diet-
induced autophagic flux in adiponectin knockout (AdKO) mice. In addition, when autophagy was 
impaired in vitro through pharmacological inhibition or in a cell line overexpressing an inactive 
mutant of ATG5, insulin sensitivity was reduced. Collectively these findings elucidate the vital 
connections between adiponectin action, autophagy, oxidative stress and insulin sensitivity.  
 
Furthermore, in skeletal muscle, adiponectin has been found to exert its anti-diabetic 
properties by directly stimulating glucose utilization via increased glucose uptake and increased 
GLUT4 translocation [111]. These processes are mediated by various receptors and 
downstream signaling events. Briefly, adiponectin binds to its two primary receptor isoforms 
AdipoR1 and AdipoR2, although T-cadherin is another alternative adiponectin receptor that 
competitively binds only the hexameric and HMW forms of adiponectin [98, 112]. APPL1 
(adaptor protein containing pleckstrin homology domain, phosphotyrosine binding (PTB) domain 
and leucine zipper motif) is the best characterized protein that binds with adiponectin receptors 
to sequentially activate downstream signaling pathways involving adenosine monophosphate-
activated protein kinase (AMPK), p38 mitogen-activating protein kinase (MAPK), peroxisome 
proliferator-activated receptor alpha (PPARα) and RAS-associated protein Rab5 [113]. The 
importance of APPL1 was first demonstrated [113] by showing that APPL1 knock down with 
siRNA abolished adiponectin-stimulated GLUT4 translocation and glucose uptake in muscle 
cells. 
 
The anti-inflammatory and cardioprotective effects of adiponectin have been linked to its 
ability to decrease ER stress and apoptosis. In H9c2 cardiomyocytes, adiponectin has been 
shown to reduce genes associated with ER stress such as HSPa5, ATF6 and GRP94, as well 
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as genes associated with inflammation such as TNFalpha and MCP1 [114]. In addition 
adiponectin can reduce cardiomyocyte cell death induced by palmitate, therefore contributing to 
its ability to protect against metabolic dysfunction-associated heart failure [115].   
 
Moreover, adiponectin has been shown to have positive effects on lipid metabolism as it 
increases fatty acid uptake and oxidation, increases ceramide catabolism and decreases the 
esterification of fatty acids to triglycerides [116]. As an example, one study showed that in 
mouse skeletal muscle, low doses of gAd increased expression of molecules involved in fatty-
acid transport, combustion and energy dissipation such as CD36, acyl-CoA oxidase and 
uncoupling protein (UCP)2, which ultimately led to a decrease in skeletal muscle triglyceride 
content [109].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
33 
 
1.6. Research Objectives, Experimental Model and Hypothesis  
 
In light of the serious health implications posed by obesity-mediated lipotoxicity, the 
goals of my project have been to:  
1) examine how lipotoxicity, induced by palmitate, influences ER stress, autophagy and 
apoptosis in skeletal muscle cells. 
2)  investigate the cross talk between ER stress, autophagy and apoptosis 
3)  explore how adiponectin regulates these processes. 
 
 Briefly, I have used an in-vitro model of lipotoxicity, induced by treatment of L6 rat 
skeletal muscle cells with palmitate, a common saturated free fatty acid. I have used well 
established methods and also developed new approaches in our laboratory to accurately 
examine autophagy, ER stress and apoptosis. Full length recombinant adiponectin (fAd) was 
utilized to study the direct effects this adipokine has on the cellular processes described above.   
 
 My hypothesis is that palmitate-induced lipotoxicity will increase ER stress in skeletal 
muscle cells, with subsequent development of apoptosis. I also propose that autophagy will be 
activated as a compensatory cellular mechanism to alleviate ER stress. Finally, I expect that fAd 
will directly increase autophagic flux and that this will contribute to its cytoprotective effects.  
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Chapter 2: Materials and Methods  
 
2.1. Cell Culture and Treatment of L6 cells 
 
Rat L6 myoblasts were grown and maintained under 5% CO2 at 37°C in alpha-minimum 
essential medium (5.5mM glucose AMEM; Wisent, St.Bruno, QC) containing 10% (v/v) fetal 
bovine serum (FBS; Wisent, St.Bruno, QC) and 1% antibiotic-antimycotic (Wisent, St.Bruno, 
QC). When differentiation of L6 wild type (wt) myoblasts into myotubes was necessary, plated 
cells were cultured in 2% FBS AMEM for approximately 5-7 days.  
 
Prior to experimental treatments, cells were starved for 4h in 0.5% FBS AMEM. 
Palmitate (Pal) treatment (sodium palmitate; Sigma-Aldrich) pre-conjugated with fatty-acid free 
bovine serum albumin (BSA; Sigma-Aldrich) in 2:1 molar ratio,was administered at 250μM to 
model lipotoxicity, and an equal volume of a solution consisting of 0.5% FBS AMEM 
supplemented with fatty-acid free BSA was administered to control cells. Tunicamycin (Tun; 
Sigma-Aldrich) was used as a positive control to induce ER stress, at 8 μg/ml. Rapamycin (Rap; 
Sigma-Aldrich) was used as a positive control to induce autophagy at 1 μM. Hydrogen peroxide 
(H2O2; Sigma-Aldrich) was administered to cells at a concentration of 500µM as a positive 
control for apoptosis. Where necessary, 1h prior to adding the palmitate treatment or control 
BSA solution, cells were pretreated with 30µM salubrinal (Sal; Sigma-Aldrich) to inhibit ER 
stress by keeping the UPR active through prevention of dephosphorylation of peIF2α. When it 
was necessary to inhibit autophagy, 50µM chloroquine (Chl; Invitrogen) was added to cells 1h 
prior to treatment, to inhibit the fusion of autophagosomes to lysosomes. Where necessary, 1h 
prior to adding the palmitate treatment or control BSA solution, cells were pretreated with 5µg/ml 
recombinant full length adiponectin (fAd), that had been produced in a mammalian expression 
35 
 
system (i.e. human embryonic kidney 293 cells; HEK293), to enable the post-translational 
modifications necessary for proper biological activity of fAd as indicated in Fang et al [117].  
 
 
2.2. Thioflavin T (ThT) Fluorescence Assay  
 
ER stress was analyzed using ThT (Sigma-Aldrich), a benzothiazole dye that exhibits 
enhanced green fluorescence upon binding to protein aggregates. A measured increase in ThT 
fluorescence directly correlates to the amount of accumulated proteins and the degree of UPR 
activation [36].  
 
Confocal Microscopy  
L6 wt myoblasts were grown on cover slips in 6 or 12 well plates and were treated as required. 
ThT solution was added in the last 40 minutes of the treatment at 5µM. Following the end of the 
treatment time, the media was aspirated and the cells were gently rinsed with phosphate-
buffered saline (PBS; Wisent) two times. They were then fixed with 4% paraformaldehyde 
(Sigma-Aldrich) for 30 min in the dark at room temperature. Following fixation, the cells were 
gently rinsed three times with PBS. Using Vecta Shield mounting medium for fluorescence with 
DAPI (Vector Laboratories Inc., Burlingame, CA), the cover slips were mounted onto slides and 
analyzed using a confocal microscope within a day’s time. 
 
Spectrometry 
L6 wt myotubes were grown in a 24 well plate and were treated as required. ThT solution was 
added in the last 40 minutes of the treatment at 5µM. Following the end of the treatment time, 
the media was aspirated and cells were rinsed with PBS, which was also aspirated. A volume of 
150µl of 0.1% Triton X in PBS was added, and the cells were scraped on ice. A volume of 100ul 
was pipetted into a 96 well black bottom plate and the fluorescence signal of the ThT dye was 
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measured using a spectrometer (485nm/535nm, 1s reading). The values were normalized to 
protein concentration obtained using BCA protein assay kit (Thermo Scientific).  
 
 
2.3. GRP78mcherry Fluorescence Microscopy and Quantification  
 
To monitor the transcriptional output of the UPR in response to ER stress, a reporter 
construct, mCherry protein under the control of the GRP78 promoter, was used.  
The -304GRP78-mCherry sequence from the vector supplied by Dr. Allen Volchuk (University of 
Toronto) was PCRed with restriction sites introduced on each end. At the 5’ end we introduced 
an AgeI site, at the 3’ we introduced a PacI site. Upon PCR and purification, we TOPO cloned 
and then excised the fragment using AgeI/PacI sites and ligated it into the retroviral cloning 
vector pQCXIP using the same sites. The viral vector was then transfected into HEK-
derived packaging cell line, EcoPack 2-293 (Clontech), expressing the MMLV Gag, Pol and 
Env proteins. The culture medium containing the virus was collected 48 hours post transfection. 
100 ul of the collected supernatant, or viral soup, was directly applied to L6 cells in presence of 
polybrene (4ug/ml) in 10 cm culture dish on the next day after being seeded. Cells were 
incubated with the virus for 24 hours in the incubator, and the medium was replaced with fresh 
growth medium containing the selection antibiotic, puromycin (2ug/ml) (Sigma Aldrich). The pool 
of cells resistant to the antibiotic was then selected and maintained. The L6 GRP78mcherry 
stable cell line exhibits low basal mCherry expression and a marked increase in red 
fluorescence following initiation of ER stress [118].  
 
For microscopy analysis, L6 GRP78mcherry myoblasts were grown on cover slips in 6 or 
12 well plates, and treated as required. At the end of the treatment time, the media was 
aspirated, the cells were rinsed with PBS, fixed with 4% paraformaldehyde for 20 min in the 
dark at room temperature, and rinsed with PBS again. The cover slips were mounted on slides 
using DAKO fluorescent mounting medium (DAKO North America Inc, CA). Images were 
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obtained using a confocal microscope and Image J software was used to quantify mean 
fluorescence of 30-50 cells per condition.  
 
2.4. Cell Lysis and Western blotting 
 
After the required treatments, cells were washed in PBS and solubilized in RIPA buffer 
(50mM Tris, 150mM NaCl, 0.1% SDS, 1% Triton X, BioShop Inc and 0.5% sodium 
deoxycholate, Sigma-Aldrich) containing protease inhibitor cocktail (cOmplete ULTRA tablets 
Mini; Roche) and phosphatase inhibitor cocktail (Calbiochem). Each lysate was transferred to 
Eppendorf tubes and further lysed by passing five times through a 25 gauge needle/syringe. 
After each sample was centrifuged at 12,000 rpm for 5 minutes at 4°C, the supernatant was 
collected, and cell pellet was discarded. Protein concentration was obtained using BCA protein 
assay kit (Thermo Scientific), and loading samples were prepared containing equal µg of 
protein. The samples were heated at 60°C for 10 minutes, and then loaded onto an SDS-PAGE 
gel. After protein transfer, the appropriately cut sections of the PVDF membrane (Bio-Rad) were 
incubated with primary antibody solutions at 4°C overnight. The membranes were then 
incubated in the appropriate horse-radish peroxidase (HRP)-linked secondary antibody 
solutions for 1h and immunoblots were developed using enhanced chemiluminescence 
(Western Lighting Plus ECL; Perkin and Amersham HyperfilmTM ECL; GE Health Care). 
Densitometric quantification of Western blot bands was conducted using Bio-Rad Quantity One 
software.  
 
The following primary antibodies were used: peIF2α (ser51), LC3B and caspase 3 
(1:1000; Cell Signaling; Beverly, MA), p62 (1:1000; BD Transduction Laboratories), and 
caspase 12 (1:1000; Sigma-Aldrich). The following secondary antibodies were used: anti-rabbit, 
anti-mouse and anti-rat (1:10,000; Cell Signaling; Beverly, MA). βActin (1:1000; Cell Signaling; 
Beverly, MA) was used as a loading control.  
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2.5. Endogenous LC3 Immunofluorescence Microscopy  
 
Immunofluorescence of LC3 tagged with Alexa Fluor 488 goat anti-rabbit secondary 
antibody (Invitrogen) was used to visualize endogenous LC3 puncta, using confocal 
microscopy. The puncta exhibited green fluorescence, indicative of the induction of autophagy 
and formation of autophagosomes. Briefly, L6 wt myoblasts were grown on cover slips in 6 or 12 
well plates and treated as required. They were then washed with PBS three times, fixed with 4% 
paraformaldehyde for 20 min, and washed with PBS again. The cells were quenched first with 
1% glycine in PBS for 1 min, then in 0.1% glycine in PBS for 10 min. After washing again three 
times with PBS, 0.1% Triton X 100 in PBS was added for 3 min, and then the cells were washed 
with PBS again three times. Blocking took place for 30min in 3% BSA in PBS, after which the 
cells were incubated overnight at 4°C with 1:500 primary LC3B antibody in 3% BSA in PBS. The 
next day the cells were washed three times with PBS, incubated with 1:1000 secondary 
antibody in 3% BSA in PBS for 1h at room temperature in the dark and washed three times with 
PBS again. The slides were then mounted on slides using Vecta Shield mounting medium for 
fluorescence with DAPI, and analyzed using confocal microscopy.   
 
2.6. Magic Red Cathepsin B Assay for Lysosomal Activity  
 
The activity of proteolytic lysosomal enzyme cathepsin B, may be taken as an indicator 
of autolysosomal activity in the later stage of autophagy. The Magic Red Cathepsin B Assay Kit 
(ImmunoChemistry Technologies) employs the cresyl violet (CV) fluorogenic substrate CV-(Arg-
Arg)2 or CV-(RR)2. When the fluorophore is di-substituted with two R-R dipeptide cathepsin B 
targeting sequences, it is non-fluorescent, but the active cathepsin B lysosomal enzyme will 
catalyze the hydrolysis of the two R-R target sequences, which when cleaved from the Magic 
Red molecule, will convert it to the red fluorescent form.  
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Briefly, L6 wt myoblasts were grown on cover slips in 6 or 12 well plates and treated as 
required. They were then washed with PBS three times, fixed with 4% paraformaldehyde for 20 
min, and washed with PBS again. The cells were quenched first with 1% glycine in PBS for 1 
min, then in 0.1% glycine in PBS for 10 min. After washing again three times with PBS, 0.1% 
Triton X 100 in PBS was added for 3 min to permeabilize cells, and then the cells were washed 
with PBS again three times. Blocking took place for 30min in 3% BSA, after which the Magic 
Red reagent was added directly to the blocking solution. According to the manufacturer’s 
protocol, 40ul of 26x diluted Magic Red per 1ml of blocking solution was added for 30 min. The 
cells were washed with PBS three times and the cover slips mounted on slides using Vecta 
Shield mounting medium for fluorescence with DAPI. The fluorescence signal (ex 540-590 nm, 
em >610nm) was then detected with confocal fluorescence microscopy.  
 
2.7. Inhibition of Autophagy using ATG5K130R Dominant Negative Mutant  
 
To elucidate the potential relationship between the processes of autophagy and ER 
stress, the dominant negative mutant L6 stable cell line ATG5K130R was created. The target 
sequence RFPATG5-K130R from the vector pmCherry-ATG5-K130R (Addgene) was subcloned 
into the retroviral cloning vector pQCXIP. The viral vector was then transfected into HEK-
derived packaging cell line, EcoPack 2-293 (Clontech), expressing the MMLV Gag, Pol and 
Env proteins. The culture medium containing the virus was collected 48h post transfection. 100 
ul of the collected supernatant, or viral soup, was directly applied to L6 cells in presence of 
polybrene (4ug/ml) in 10 cm culture dish on the next day after being seeded. Cells were 
incubated with the virus for 24h in the incubator, and the medium was replaced with fresh 
growth medium containing the selection antibiotic, puromycin (2ug/ml) (Sigma Aldrich). The pool 
of cells resistant to the antibiotic was selected and maintained. The ATG5K130R dominant 
negative mutant is defective in conjugating to Atg12 on the lysine (K) residue, as lysine has 
been replaced with arginine. This inhibits LC3 incorporation into the early autophagosome, thus 
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inhibiting autophagy by inhibiting autophagic vacuole formation [119, 120]. Empty vector (EV) 
cells were used as the corresponding control.  
 
2.8. Caspase 3/7 Green Detection Reagent Assay 
 
CellEvent Caspase-3/7 Green Detection Reagent (Life Technologies) was used to 
visualize apoptotic cells under a confocal microscope, by identifying those cells that showed a 
bright green fluorescence signal in their nuclei. The reagent is a four amino acid peptide (DEVD) 
conjugated to a nucleic a cid binding dye with an absorption/emission maxima of ~502/530 nm. 
When caspase 3/7 is activated in apoptosis, cleavage of the DEVD peptide occurs which allows 
the dye to bind to DNA and produce a bright, fluorogenic response. L6 wt myoblasts were grown 
on cover slips in 6 or 12 well plates and were treated as required. Caspase 3/7 Green Detection 
Reagent was added in the last 30 minutes of the treatment at 8µM, following which the medium 
was gently aspirated and the cells were gently rinsed with PBS. Fixation was conducted with 4% 
paraformaldehyde for 20min, and gently rinsed again with PBS. The cover slips were then 
mounted on slides using Vecta Shield Mounting Medium containing DAPI and analyzed using 
confocal microscopy. Quantification of the images was done by calculating the mean 
percentage of apoptotic cells exhibiting a nuclear green fluorescence signal.   
 
2.9. MTT Assay 
 
Cell viability was determined using 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium 
bromide (MTT) assay. L6 myoblasts were seeded, grown and treated in a clear 96 well plate. 
Approximately 2 hours before the end of the treatments, the cells were incubated with MTT 
solution (5 mg/mL in PBS; Sigma-Aldrich) at 37°C. During this time the yellow MTT was reduced 
in the mitochondria of living cells to an insoluble formazan that precipitated as purple crystals. 
The media was then gently aspirated and the purple formazan crystals were dissolved using 
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DMSO. Using a spectrometer, the absorbance was measured at 550nm. The intensity of the 
purple color directly related to the amount of viable cells present.   
 
2.10. Statistical Analysis 
Values are given as mean + SEM, unless indicated otherwise. Statistical analysis was 
conducted using GraphPad Prism version 3 software. Normality of data was tested using 
Kolmogorov-Smirnov and Shapiro-Wilk tests. If the data set was found to have normal 
distribution, parametric tests were used. Specifically, one-way ANOVA with Tukey’s post hoc 
test was used to compare three or more groups, and one-tailed unpaired t-test was used to 
compare two groups. If the data was not normal, non-parametric tests were used. Specifically, 
Kruskal-Wallis with Dunn’s multiple comparison post hoc test was used to compare three or 
more groups, and one-tailed Mann-Whitney U test was used to compare two groups. P<0.05 
was considered statistically significant. 
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Chapter 3: Effect of Palmitate on ER Stress, Autophagy and 
Apoptosis and Regulation by Adiponectin  
 
3.1. Effect of Palmitate on ER Stress and Autophagy  
 
3.1.1. Introduction 
 
It is well known that excessive amounts of saturated fatty acids promotes lipotoxicity in 
non-adipose tissues, which greatly increases the risk for developing serious health problems 
such as insulin resistance, dyslipidemia, obesity and cardiovascular diseases [121]. It has 
therefore become important to better understand the cellular mechanisms and processes that 
are involved in mediating the harmful consequences of lipotoxicity.  
 
To this end, much research in the field has demonstrated a close relationship between 
lipotoxicity and ER stress, with the proposal that ER stress may represent an early component 
of lipotoxicty [44, 121]. As indicated in Chapter 1, Section 1.3.1.2, excessive lipids may disrupt 
proper ER functioning. Elevated palmitate levels in primary rat hepatocytes and H4IIEC3 
hepatic cells compromised the ER’s ability to maintain calcium stores, and instead promoted the 
net redistribution of intracellular calcium from the ER to the mitochondria[122]. This increased 
citric acid cycle flux, mitochondrial glutamine metabolism, and production of reactive oxygen 
species, ultimately leading to cellular dysfunction and apoptosis [122]. Palmitate has also been 
observed to lead to protein accumulation[44], perhaps through its impairment of ER-to-Golgi 
protein trafficking which was visualized via use of GFP-tagged, temperature-sensitive reporter 
protein VSVG in MIN6 cells[43]. In control cells, under the permissive temperature of 32°C, 
VSVG moved from colocalizing with ER marker calnexin to colocalizing with Golgi marker 
GOLGA2 within 20 minutes. This transition was severely impaired by palmitate pretreatment 
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[43]. A more direct mechanism for palmitate’s effects on ER function was found by Borradaile et 
al [123] who reported that palmitate disrupted ER membrane structure and integrity by 
becoming incorporated into saturated phospholipid and triglyceride species in microsomal 
membranes of Chinese hamster ovary cells. This membrane remodeling accompanied 
prominent dilatation of the ER and redistribution of protein-folding chaperones to the cytosol 
[123]. As discussed in Chapter 1, Section 1.3.1.2. the induction of ER stress by palmitate has 
been shown to upregulate UPR markers across several cell types i.e. in H9c2 cardiomyocytes 
[44], HepG2 liver cells [45] and L6 skeletal muscle myotubes [47]. In insulin-sensitive tissues, 
the activation of ER stress has been linked to insulin resistance, as it has been shown that the 
IRE1/JNK pathway may lead to a decrease in insulin signaling through phosphorylation of IRS1 
[124] and a decrease in phosphorylation of Akt [45, 47].       
 
The effect of obesity and lipotoxicity on autophagy has also come under investigation, 
with some studies showing that excess lipid accumulation upregulates autophagy and some 
others demonstrating that it inhibits autophagy. For example, autophagy has been understood 
to be a protective mechanism that is stimulated to combat lipotoxicity in several models. It 
degrades excess lipids via lipophagy in liver cells thereby regulating lipid metabolism and 
protecting against hepatic steatosis [58], and it protects against palmitate-induced beta cell 
death in INS1 cells [125]. However on the other hand, an inhibition of autophagic flux has been 
reported in response to conditions of obesity, which may itself contribute to further metabolic 
complications. Masini et al [126] states that both the pancreas of diabetics orpancreatic beta 
cells treated with fatty acids exhibited impaired autophagic turnover. This was characterized by 
abnormal accumulation of autophagosomes and reduced gene expression of lysosomal proteins 
cathepsins B and D, and LAMP2, which ultimately may contribute to beta cell death and 
exacerbate type 2 diabetes. Gukovsky et al [54] similarly noted the inhibition of autophagic flux 
in acute pancreatitis, which has been known to be caused by obesity. They stated that 
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accumulation of large autophagic vacuoles was observed in acinar cells, and corresponded to 
increased levels of LC3II and p62. The authors go on to describe how impairment of autophagy 
may contribute to the upregulation of inflammation, such as through the activation of NF-κB 
pathway and the production of ROS required for NLR3P inflammasome activation[54]. Taken 
together, these data seem to suggest an overall protective role for autophagy, though if it is 
specifically upregulated or downregulated by lipid accumulation may be unclear and appears to 
depend on the cell type and specific physiological conditions.  
 
The goals of this study were to first elucidate whether palmitate exposure, my model for 
lipotoxicity, increases or decreases ER stress and autophagy in L6 rat skeletal muscle cells. It is 
of interest to investigate this as the regulation of these processes by lipotoxicity may have 
repercussions on important endpoints such as insulin signaling/glucose metabolism and 
apoptosis. To study changes in the processes of ER stress and autophagy induced by 
palmitate, I have used well-established methods such as immunoblotting for UPR and 
autophagic protein markers, in addition to setting up protocols used for the first time in our 
laboratory such as ThT assay for assessing protein accumulation, GRP78mcherry microscopy 
that utilizes a reporter construct to visualize enhanced expression of the ER chaperone GRP78, 
and Magic Red Cathepsin B assay for assessing lysosomal activity, which may provide an 
indication of autolysosomal function. I used tunicamycin as a positive control for inducing ER 
stress as it causes accumulation of unfolded glycoproteins in the ER, leading to ER stress. It 
does this through blockage of the initial step of glycoprotein biosynthesis in the ER, as it is an 
inhibitor of the UDP-N-acetylglucosamine-dolichol phosphate N-acetylglucosamine-1-phosphate 
transferase (GPT) [38]. 
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3.1.2. Results  
 
 
3.1.2.1. Palmitate induces ER stress, as evidenced by increased cellular protein 
aggregation, increase in GRP78mcherry expression and upregulation of the UPR  
 
 The accumulation of proteins in the cell, an important hallmark of ER stress was 
assessed with ThT Assay via both confocal microscopy and spectrometry. Palmitate was found 
to increase protein aggregation as visualized in Figure 2.1A where 24h Pal shows an apparent 
increase in green fluorescence of ThT dye compared to the control condition. Analysis by 
spectrometry demonstrated a significant increase of ThT fluorescence in palmitate treatment 
compared to the control condition (Figure 3.1B). Tunicamycin, was used as a positive control to 
induce ER stress and also appeared to show marked protein aggregation in Figure 3.1A and a 
significant increase in fluorescence in Figure 3.1B, thereby substantiating the validity of the 
assay. The actual induction of ER stress by palmitate was evidenced by an increase in the 
expression of GRP78 chaperone protein that is known to induce the UPR when it is recruited for 
protein folding and becomes uncoupled from the three ER transmembrane proteins PERK, IRE1 
and ATF6 [40]. Figure 3.2 demonstrates greater red fluorescence of the GRP78mcherry 
reporter construct in 24h Pal compared to control, and the upregulation of GRP78 was further 
increased with prolonged exposure of fatty acid at 48h Pal (Figure 3.2B). Tunicamycin similarly 
demonstrated an increase in GRP78mcherry expression. Direct evidence for the upregulation of 
the UPR in response to palmitate was provided in Figure 3.3 which illustrates that palmitate 
demonstrates a trend towards upregulating the UPR marker peIF2α, as assessed by Western 
blot. The difference in peIF2α expression between palmitate and control was significant at the 
24h time point.   
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Figure 3.1. Palmitate induces ER stress by increasing cellular protein aggregation, as assessed by ThT 
Assay.  
(A) Representative image for ThT microscopy in L6 wt myoblasts | 24h | n=4 | An apparent increase in 
protein aggregation is visualized in 24h Pal compared to 24h Con. The positive control for ER stress, 24h 
Tun, appears to show marked protein aggregation.  
(B) Quantification graph from ThT spectrometry in L6 wt myotubes | 24h | n=6 for Con and Pal; n=5 for 
Tun | Protein aggregation is significantly upregulated by 24h Pal and 24h Tun as compared to 24h Con, 
as denoted by * (p<0.05) | Statistical analysis done by one-way ANOVA with Dunnett’s multiple 
comparison post-hoc test. Normal distribution was verified by Shapiro-Wilk and Kolmogorov-Smirnov 
tests. 
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Figure 3.2. An increase in GRP78mcherry expression provides evidence for induction of ER stress by 
palmitate.  
(A) Representative image for microscopy of L6 GRP78mcherry myoblasts. 
(B) Quantification graph of L6 GRP78mcherry microscopy using Image J software. Each column 
represents the mean of 30-50 cells | 24h, 48h | n=3 | Significantly greater red fluorescence of 
GRP78mcherry reporter construct is observed in 24h Pal and 24h Tun compared to 24h Con, and 48h 
Pal and 48h Tun compared to 48h Con, indicating an increase in ER stress induction by palmitate and 
tunicamycin at these time points, as denoted by * (p<0.05). ER stress induction is significantly increased 
with prolonged exposure to palmitate and tunicamycin, as 48h Pal is significantly greater than 24h Pal, 
and 48h Tun is significantly greater than 24h Tun, as indicated by # (p<0.05). 48h Con shows significantly 
greater red fluorescence than 24h Con, as denoted by * (p<0.05) | Statistical analysis done by Kruskal-
Wallis test with Dunn’s multiple comparison post-hoc test.  
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Figure 3.3. Palmitate demonstrates a trend towards upregulating UPR marker peIF2α, as assessed by 
Western blot  
(A) Representative Western blot images, from individual experiments, for time points 4h, 24h.  
(B) Corresponding Western blot quantification graphs for individual experiments shown in (A)  
(C) Cumulative graph of Western blot quantification | n=6 for 4h and 24h Con and Pal; n=3 for 4h, 24h 
Tun | 24h Pal and 24h Tun demonstrate significantly greater peIF2α than 24h Con, as denoted by * 
(p<0.05). 4h Tun demonstrates significantly greater peIF2α than 4h Con, as denoted by * (p<0.05). 
Statistical analyses done by Mann-Whitney U test. 
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3.1.2.2. Palmitate appears to increase autophagic flux, as evidenced by apparent 
increased autophagosome formation and lysosome activity 
 
 In my model of lipotoxicity in L6 rat skeletal muscle cells, palmitate exposure seemed to 
increase autophagosome formation, as assessed by endogenous LC3 immunofluorescence 
microscopy in Figure 3.4. An apparent increase in the amount of green LC3 puncta was visible 
in palmitate treatments over the time course 1h-24h compared to control cells. This may 
correspond to an increase in autophagosome formation, as fluorescently tagged LC3 becomes 
lipidated to its LC3II form and incorporated into the autophagosomal membrane, thereby giving 
rise to visually discernable puncta. Evidence for the progression of autophagy from its beginning 
autophagosome stage to its later degradative autolysosome stage was given by Magic Red 
Cathepsin B assay microscopy (Figure 3.5) which showed significantly greater red fluorescence 
indicating greater activity of lysosomal cathepsin B enzyme in 4h Pal and 24h Pal compared to 
corresponding controls. This increase was not evident at 48h however, an observation which 
will be discussed subsequently in chapter 4, section 4.4. Further support for increased 
autophagic flux induced by palmitate was provided by Western blotting for autophagy proteins 
LC3II and p62. Figure 3.6 demonstrates that compared to corresponding timed controls, 
palmitate may demonstrate an overall trend towards increasing LC3II and decreasing p62, 
consistent with the characteristic increased autophagosome formation and degradation of p62 
discussed in Chapter 1, Section 1.3.2.1.      
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Figure 3.4. Palmitate appears to increase autophagosome formation, as assessed by endogenous LC3 
puncta immunofluorescence (IF) microscopy. Representative IF images for time course 1h-24h | n=2 | 
Amount of LC3 puncta appears to be increased in palmitate treatments compared to control. 
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Figure 3.5. Palmitate may increase lysosome activity, as assessed by Magic Red Cathepsin B Assay 
microscopy.  
(A) Representative images for time points 4h, 24h and 48h | n=3 for 4h; n=6 for 24h; n=1 for 48h 
(B) Corresponding quantification graph of individual experiment shown in (A), done using Image J 
software. Each column represents the mean of ~50 cells  | n=1 | 4h Pal and 24h Pal show significantly 
greater red fluorescence indicating active lysosomal cathepsin B enzyme, as compared to their respective 
controls 4h Con and 24h Con, denoted by * (p<0.05). Conversely, 48h Pal shows significantly less red 
fluorescence than 48h Con, denoted by * (p<0.05). With increased duration of exposure to palmitate, red 
fluorescence significantly decreases, as 48h Pal and 24h Pal show significantly less fluorescence than 4h 
Pal, denoted by $ (p<0.05), and 48h Pal shows significantly less fluorescence than 24h Pal, denoted by # 
(p<0.05). 24h Con and 48h Con show significantly less fluorescence than 4h Con, denoted by ^ (p<0.05). 
Statistical analyses done by Kruskal-Wallis test with Dunn’s multiple comparison post hoc test.   
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Figure 3.6. Palmitate demonstrates a trend towards increasing autophagic flux, as assessed by Western 
blot for LC3II and p62.  
(A) Representative Western blot images, from individual experiments, for time points 4h, 24h.  
(B) Corresponding Western blot quantification graphs for individual experiments shown in (A)  
(C) Cumulative graph of Western blot quantification | n=8 for 4h; n=9 for 24h | Compared to 
corresponding timed controls, Pal may demonstrate an overall trend towards greater LC3II and lesser 
p62.  
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3.2. ER Stress May Induce Autophagy as a Rescue Mechanism  
 
3.2.1. Introduction 
 
As discussed in Chapter 1, Section 1.4.1, though the UPR is recognized as the primary 
well-established response of the cell to manage ER stress induced by protein overload [39], 
several studies have reported that autophagy too may be recruited as a rescue mechanism to 
ultimately attenuate ER stress, via its ability to degrade accumulated proteins and thereby 
reduce the protein overload on the cell [44, 74, 127]. Furthermore, an interesting study by 
Bernales et al [128] reported a potential role for ER-phagy, a sub-type of autophagy, in 
removing unfolded proteins from the ER. The authors observed that when ER stress was 
induced in wild type yeast cells by dithiothreitol (DTT), the expected ER expansion was 
accompanied by the formation of autophagosome-like structures, which were packed with 
membrane cisternae derived from ER. However, these ER-containing autophagosomes (ERAs) 
were not generated in cells genetically modified to express Hac1i (the yeast ortholog of XBP1), 
that is primarily involved in initiating transcriptional programs directed towards protein folding, 
maturation and degradation. This suggested that ERA formation required the actual presence of 
unfolded proteins, something that would be ameliorated in the hac1Δ cells. The authors 
therefore proposed that in response to ER stress induced by protein overload, an expanded ER 
could facilitate ER-phagy as a protective mechanism, which sequestered potentially toxic 
unfolded proteins or aggregates into distinct regions of the ER, and packaged them into ERAs 
for eventual degradation[128].  
 
 As an adaptive response to ER stress, autophagy has been shown to increase cell 
viability, by steering the cell away from ER stress-induced apoptosis. Studies in support of this 
conclusion have shown that when autophagy is pharmacologically inhibited with 3-
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methyladenine (3-MA), glomerular podocytes and breast cancer cells stimulated to undergo ER 
stress with tunicamycin or thapsigargin demonstrated increased cell death [127, 129]. The role 
of autophagy in attenuating ER stress-induced apoptosis will be discussed in more detail in 
subsequent chapters; here I will principally focus on elucidating the link between the activation 
of autophagy in response to ER stress.  
 
 As discussed in Chapter 1, Section 1.4.1, there is much evidence to show that ER stress 
directly stimulates the initial stage of autophagy, the formation of autophagosomes. Yorimitsu et 
al [76] demonstrated that tunicamycin-induced ER stress stimulated the formation of the pre-
autophagosomal structure in yeast atg11Δ cells that otherwise are inherently defective in this. 
Morever, several studies have shown that stimulation of ER stress with triggers such as 
thapsigargin, tunicamycin or poluglutamine 72 (PolyQ72) aggregates led to conversion of LC3I 
to LC3II [39, 75, 127, 129].  
 
 UPR pathways and proteins have also been implicated in the activation of autophagy 
following ER stress. As described in Chapter 1, Section 1.4.1, IRE1-deficient MEF cells or cells 
treated with JNK inhibitor SP600125, exhibited inhibition of autophagic GFP-LC3 puncta 
formation, demonstrating that the IRE-JNK pathway is involved in facilitating autophagy [39]. 
Similarly, C2C5 cells with genetically impaired PERK or eIF2α displayed reduced conversion of 
LC3I to LC3II [75]. Moreover, in HepG2 cells ATF4-siRNA suppressed ATF4 protein and mRNA 
expression and inhibited NaF- or tunicamycin- induced autophagy [130]. 
 
 The goals of this study were to investigate whether ER stress induces autophagy in my 
model of L6 rat skeletal muscle cells, and to elucidate the link between the peIF2α branch of the 
UPR and autophagic activity. Salubrinal, a dephosphorylation inhibitor of eIF2α that prolongs 
peIF2α downstream signaling [131] has been used to investigate this. In addition, I studied the 
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effect of impairing autophagy on ER stress using molecular and pharmacological approaches. 
An ATG5K130Rdominant negative mutant, that was defective in conjugating to Atg12 on the 
lysine (K) residue, was used to inhibit autophagosome formation through inhibition of LC3 
incorporation into the early autophagosome [119]. Next, a late phase autophagy inhibitor, 
chloroquine, was used to inhibit fusion of autophagosomes with lysosomes and lysosomal 
protein degradation, by increasing the pH of autophagic vacuoles and inhibiting lysosomal 
enzymes that required an acidic pH to function [49]. Previously described methods such as 
Western blotting, ThT assay, Magic Red cathepsin B assay and GRP78mcherry assay were 
also employed in this study.  
 
 
3.2.2. Results 
 
 
3.2.2.1. Tunicamycin, an established inducer of ER stress, appears to increase 
autophagic flux as evidenced by Western blotting for autophagic proteins and 
apparent increase in lysosomal activity 
 
I first verified the effect of tunicamycin in stimulating ER stress and upregulating the UPR 
through Western blotting for UPR marker peIF2α. It was found that compared to corresponding 
controls, tunicamycin appeared to show greater peIF2α at both 4h and 24h, as would be 
expected (Figure 3.7). Next, it was found that tunicamycin also appeared to upregulate LC3II 
compared to controls at 4h and 24h, while perhaps decreasing p62 (Figure 3.8). In addition, as 
observed in Figure 3.9, tunicamycin appeared to increase lysosomal activity at 4h compared to 
its corresponding control, assessed by Magic Red Cathepsin B assay microscopy which 
demonstrated an increase in red fluorescence, indicative of active cathepsin B enzyme. Taken 
together, these results may provide support for the line of thinking that ER stress may induce 
autophagy.  
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It was noted however in Figure 3.3, that at 24h, tunicamycin does not appear to elicit 
increased lysosomal cathepsin B activity compared to the control. This may indicate that 
perhaps tunicamycin’s effect to increase lysosomal activity is most prominent only in the short 
term; the reasons as to why this might be the case will be discussed in Chapter 4, Section 4.4.  
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Figure 3.7. Tunicamycin demonstrates a trend towards upregulating UPR marker peIF2α, as assessed by 
Western blot.  
(A) Western blot images, from individual experiments, for time points 4h, 24h  
(B) Cumulative graph of Western blot quantification | n=3 | Compared to corresponding timed control, Tun 
appears to show greater peIF2α. 
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Figure 3.8. Tunicamycin, an inducer of ER stress, demonstrates a trend towards increasing autophagic 
flux, as assessed by Western blot for LC3II and p62.  
(A) Western blot images for time points 4h, 24h  
(B) Cumulative graph of Western blot quantification | n=1 for LC3II; n=2 for p62 | Compared to 
corresponding timed controls, Tun may appear to demonstrate a trend towards increasing LC3II and 
decreasing p62.  
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Figure 3.9. Tunicamycin, an inducer of ER stress, appears to increase lysosomal activity, at 4h but not 
24h, as assessed by Magic Red Cathepsin B Assay microscopy. Representative images for 4h, 24h | n=1 
for 4h; n=3 for 24h | 4h Tun appears to show more overall red fluorescence, indicative of cathepsin B 
lysosomal activity than 4h con. However at 24h, Tun does not elicit such a response. This may indicate 
that perhaps Tun’s effect to increase lysosomal activity occurs more so in the short term, and dwindles in 
the long term. 
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3.2.2.2. Sustaining UPR activity and preventing dephosphorylation of eIF2α with 
ER stress inhibitor salubrinal, appears to increase lysosomal activity, as 
assessed by Magic Red Cathepsin B assay microscopy 
 
 Further evidence for the sequential link between ER stress and autophagy was provided 
by the Magic Red Cathepsin B Assay observations exhibited in Figure 3.10. It may be seen that 
pretreatment with salubrinal in both control and palmitate conditions appears to increase the red 
fluorescence, indicative of cathepsin B lysosomal activity, at both 4h and 24h. Therefore, 
keeping the UPR active by keeping the peIF2α signaling pathway active with the use of 
salubrinal could perhaps also upregulate the autophagic pathway. 
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Figure 3.10. Sustaining UPR activity by preventing dephosphorylation of eIF2α with ER stress inhibitor 
salubrinal, may increase lysosomal activity, as assessed by Magic Red Cathepsin B Assay microscopy. 
Representative images for 4h, 24h | n=1 for 4h; n=4 for 24h | Pretreatment with salubrinal in the control or 
palmitate conditions appears to increase the overall red fluorescence, indicative of cathepsin B lysosomal 
activity, at both 4h and 24h. Therefore, this may provide evidence that keeping UPR active by keeping 
peIF2α pathway active could also upregulate autophagy rescue mechanism. | Note: The images for 
control conditions are the same between Figures 3.10 and 3.9 as both figures show the same 
representative experiment, where the experimental treatments were conducted at the same time. 
Experimental treatments tunicamycin and salubrinal are shown separately for the purpose of clarifying 
discussion.   
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3.2.2.3. Inhibiting autophagy using ATG5K130R dominant negative cell line or 
pharmacological inhibitor, chloroquine appears to increase ER stress, as 
evidenced by apparent increases in protein aggregation and UPR stimulation     
 
 The expected impairment in autophagic flux exhibited by ATG5K130R dominant 
negative myoblasts was first verified by Western blotting for autophagy proteins LC3II and p62. 
As observed in Figure 3.11A, compared to EV, the control, palmitate and tunicamycin conditions 
in ATG5K130R cells appeared to show less LC3II. According to Figure 3.11B, ATG5K130R 
control and palmitate conditions exhibited significantly less LC3II than EV control and palmitate 
conditions, at both 4h and 24h. Overall, ATG5K groups appeared to demonstrate a trend 
towards increased p62, compared to EV groups. These findings correspond to a blockage in 
autophagic flux; specifically reduced incorporation of LC3 into the autophagosomal membrane 
and accumulation of undegraded p62. 
 
 The consequences of impaired autophagy on ER stress were then elucidated by various 
ER stress assays previously described. The ThT microscopy assay shown in Figure 3.12 
depicted apparent increases in overall protein aggregation in ATG5K130R cells compared to EV 
cells. This perhaps indicates that impairment in the autophagic degradative pathway leads to 
increased protein accumulation. Additionally, Figure 3.13 Western blot illustrates that compared 
to EV, the control and palmitate conditions in ATG5K130R cells exhibited significantly increased 
peIF2α, providing evidence that an impairment in autophagy may exacerbate ER stress and 
upregulate the UPR. Finally, Figure 3.14 shows that pharmacological inhibition of autophagy 
with chloroquine, may similarly upregulate ER stress, as significantly greater red fluorescence of 
GRP78mcherry reporter construct was observed in the control condition pretreated with 
chloroquine as compared to the control, and in the palmitate condition pretreated with 
chloroquine compared to palmitate. Taken together, these results may indicate that autophagy 
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does indeed help to alleviate the burden of ER stress, such that when it is compromised, ER 
stress is aggravated.  
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Figure 3.11. ATG5K130R myoblasts appear to demonstrate impaired autophagy, as assessed by 
Western blot for LC3II and p62. (A) Representative Western blot images for time points 4h, 24h (B) 
Summary graph of Western blot quantification | n=7 for con and Pal; n=1 for Tun | ATG5K 4h and 24h 
Con exhibit significantly less LC3II than EV 4h and 24h Con respectively, as denoted by * (p<0.05). 
ATG5K 4h and 24h Pal exhibit significantly less LC3II than EV 4h and 24h Pal respectively, as denoted 
by # (p<0.05). Statistical analyses done by Mann-Whitney U test. | Overall, ATG5K groups appear to 
demonstrate a trend towards increased p62, compared to EV groups. | This may correspond to reduced 
incorporation of LC3 into the autophagosomal membrane and accumulation of undegraded p62. 
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Figure 3.12. ATG5K130R cells appear to demonstrate increased protein aggregation, as assessed by 
ThT microscopy assay. Representative images for ThT Microscopy | 24h | n=1 | An apparent increase in 
protein aggregation may be visualized overall in ATG5K cells compared to EV cells, perhaps indicating 
that impairment in autophagic degradative pathway may lead to increased protein accumulation.  
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Figure 3.13. ATG5K130R myoblasts demonstrate increased expression of UPR marker, peIF2α, as 
assessed by Western blot.  
(A) Representative Western blot image for time point 24h  
(B) Cumulative graph of Western blot quantification | n=6 | Compared to EV groups, ATG5K groups 
exhibit greater peIF2α, which may indicate greater ER stress, perhaps as a result of the autophagy 
rescue mechanism being impaired. | ATG5K 24h Con demonstrates significantly more peIF2α than EV 
24h Con, denoted by * (p<0.05). ATG5K 24h Pal demonstrates significantly more peIF2α than EV 24h 
Pal, denoted by # (p<0.05). Statistical analyses done by Mann-Whitney U test.  
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Figure 3.14. Inhibiting autophagy with chloroquine increases GRP78mcherry expression and induction of 
ER stress  
(A) Representative images for GRP78mcherry microscopy  
(B) Quantification graph of GRP78mcherry microscopy using Image J software. Each column represents 
the mean of 30-50 cells | 24h | n=2 | 24h palmitate significantly increases overall red fluorescence of 
GRP78mcherry reporter construct compared to 24h control, denoted by * (p<0.05). Pretreatment of 
control condition with chloroquine significantly increases GRP78mcherry fluorescence compared to 
control, denoted by * (p<0.05). Pretreatment of palmitate condition with chloroquine significantly increases 
GRP78mcherry fluorescence compared to control denoted by * (p<0.05), compared to palmitate denoted 
by # (p<0.05) and compared to control condition pretreated with Chl denoted by $ (p<0.05). | Statistical 
analysis done by Kruskal-Wallis test with Dunn’s multiple comparison post-hoc test.  
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3.3. Prolonged, Excessive or Uninhibited ER Stress Induces 
Apoptosis  
 
 
3.3.1. Introduction 
 
 
As discussed in Chapter 1, Sections 1.4.1 and 1.4.3.4, and Chapter 3, autophagy may 
be induced in the cell to help alleviate ER stress by degrading excessive proteins, and through 
this action it may help circumvent ER stress-induced apoptosis [44, 127]. Many studies have 
been conducted to demonstrate autophagy’s cytoprotective role in this regard. The stimulation 
of autophagy using rapamycin has been found to decrease ER stress-induced apoptosis in 
C2C5 cells [75], H9c2 cells [44], HeLa cells [39] and diabetic Akita mice [96]. Meanwhile, loss of 
function of autophagy in ER stress conditions has contributed to uninhibited ER stress and 
increased apoptosis. For instance, ATG5-deficient MEF cells exposed to tunicamycin [39], or 
bafilomycin-treated H9c2 cells stressed with palmitate [44], exhibited increased apoptosis. 
Lastly the suggestion that autophagy may be activated as a protective mechanism downstream  
of the UPR’s pPERK/peIF2α signaling pathway may be supported by work which showed that 
suppression of the transcription factor ATF4 by ATF4-siRNA in HepG2 cells, completely 
inhibited the autophagy induced by NaF or tunicamycin [130]. Taken together, these studies 
point to autophagy as being a protective mechanism that may be recruited to alleviate ER 
stress-induced apoptosis. However it is important to understand that if the intensity or duration 
of ER stress surpasses the cell’s ability to cope via the UPR or autophagy, then apoptotic 
programmes are likely to take over and move the cell towards ER stress-induced cell death [35, 
51].   
 
The ER has been found to induce apoptosis via several pathways. Upon prolonged ER 
stress, the UPR protein IRE1α recruits TNF receptor-associated factor 2 (TRAF2), which in turn 
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recruits and activates ASK, a component of the c-Jun N-terminal kinase (JNK) pathway. JNK is 
translocated to the mitochondrial membrane and stimulates intrinsic apoptosis through the 
phosphorylation of Bim, a BH3-only Bcl-2 protein, which then leads to Bax-dependent 
cytochrome c release and activation of caspase 9 initiator caspase [132],  which then cleaves 
and activates effector/executioner caspases, caspase 3 and caspase 7 [51]. Among the 
executioner caspases, caspase 3 is considered the most important [62]. It can be activated by 
any of the initiator caspases i.e. caspase 8, caspase 9 or caspase 10, and in apoptotic cells, 
cleaved caspase 3 cleaves the inhibitor of the endonuclease CAD (ICAD) to release CAD, 
which then degrades chromosomal DNA and causes chromatin condensation. In addition, 
caspase 3 also induces cytoskeletal reorganization and disintegration of the cell into apoptotic 
bodies [62]. The other branches of the UPR have also been implicated in ER stress-induced 
intrinsic apoptosis. As indicated in Chapter 1, Section 1.4.2, CHOP which is part of the 
pPERK/peIF2α pathway promotes the transcription of proapoptotic Bim which helps facilitate 
MOMP [74], while ATF6 signaling upregulates CHOP during prolonged ER stress, and can 
therefore also contribute to apoptosis [81]. 
 
Another important ER stress-mediated apoptotic pathway occurs through the activation 
of caspase 12, which predominantly localizes in the ER [75, 133, 134]. Nakagawa et al [133] 
has shown that caspase 12 is specifically activated in apoptosis caused by ER stress-inducing 
stimuli, but not in apoptosis caused by membrane- or mitochondrial-targeted signals. In 
particular, procaspase 12 failed to be activated by apoptosis caused by serum deprivation in 
PC12 cells, or by apoptosis caused by cyclohexamide, TNF or anti-Fas in W4 cells. However 
treatment of PC12 cells or embryonic fibroblast cells with ER stressors such as brefeldin A 
which inhibits ER to Golgi transport, tunicamycin which inhibits N-glycosylation in ER, 
thapsigargin and calcium ionophore A23187 which disrupt intracellular calcium homeostasis, 
successfully induced cleavage of procaspase 12 [133]. Hitomi et al [135] have also shown that 
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activated caspase 12 can activate cytoplasmic caspase 3 during ER stress, as both caspase 3 
activation and cleavage of procaspase 3 were significantly increased in SK-N-SH cells that 
stably expressed caspase 12, compared to empty vector cells, when treated with tunicamycin 
[135]. 
 
The goals of this study have been to investigate the effect of tunicamycin and palmitate 
on apoptosis through caspase activation in L6 rat skeletal muscle cells, and to examine the 
effect on apoptosis of inhibiting autophagy via chloroquine, as well as inhibiting ER stress 
through sustaining the peIF2α UPR pathway with salubrinal. To do so, I have used various 
assays for studying apoptosis such as Western blotting for apoptotic protein markers, MTT cell 
viability assay and a fluorescence microscopy assay for determining caspase activity. An 
additional goal of this study was to interpret results in the context of the previous studies 
described in Chapters 2 and 3 and to elucidate potential links and cross talk between ER stress, 
autophagy and apoptosis caused by palmitate and tunicamycin in this model of L6 rat skeletal 
muscle cells.  
 
 
3.3.2. Results 
 
 
3.3.2.1. Tunicamycin and palmitate, both stimulators of ER stress, appear to induce 
apoptosis by activating caspase activity, as evidenced by Western blotting  
 
 In my model of L6 skeletal muscle cells, Western blotting indicated that tunicamycin 
appeared to increase ER-resident caspase 12 at 24h compared to control (Figure 3.15), 
providing evidence that it may induce an ER-specific apoptosis pathway. It was additionally 
found that both tunicamycin and palmitate, appeared to increase expression of another 
apoptotic marker, cleaved caspase 3, compared to control (Figure 3.16). Expression of cleaved 
caspase 3 may demonstrate a trend towards being greater at the longer time point of 24h than 
at 4h (Figure 3.16).  
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Figure 3.15. Tunicamycin, an inducer of ER stress, may increase caspase 12, as assessed by Western 
blot.  
(A) Western blot image for time point 24h  
(B) Graph of Western blot quantification | n=1 | Compared to the control, Tun appears to show greater 
caspase 12. 
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Figure 3.16. Palmitate and tunicamycin, both stimulators of ER stress, demonstrate a trend towards 
increasing cleaved caspase 3, as assessed by Western blot in L6 wt myotubes.  
(A) Western blot images, from individual experiments, for time points 4h, 24h in L6 wt myotubes.  
(B) Cumulative graph of Western blot quantification in L6 wt myotubes | n=3 | Compared to the 
corresponding timed controls, both Pal and Tun may appear to induce apoptosis, as evidenced by 
apparent increases in cleaved caspase 3. Expression of cleaved caspase 3 may be greater at the longer 
time point of 24h compared to 4h.  
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3.3.2.2. Apoptosis induced by palmitate may be exacerbated by inhibiting autophagy with 
chloroquine, and may be ameliorated by inhibiting ER stress through sustaining peIF2α UPR 
pathway with salubrinal, as evidenced by caspase activity and MTT cell viability assay 
 
 Consistent with Figure 3.16, Western blotting in Figure 3.17 demonstrates that with a 
24h treatment, both palmitate and tunicamycin appeared to increase cleaved caspase 3 levels 
compared to control. However, in addition, Figure 3.17 illustrates that inhibiting autophagy with 
chloroquine in both control and palmitate conditions may increase cleaved caspase 3 further. 
Furthermore inhibiting ER stress with salubrinal in the palmitate treatment may decrease 
cleaved caspase 3 compared to palmitate. This latter difference appears to be most apparent in 
the upper Western blot image in Figure 3.17A, which is quantified in the upper graph of Figure 
3.17B.  
 
 L6 wt myoblasts analyzed with caspase 3/7 green detection reagent microscopy 
appeared to demonstrate similar trends. As evidenced in Figure 3.18, 24h Pal significantly 
increased the quantity of apoptotic cells i.e. those cells showing green nuclear fluorescence 
compared to control. Though statistically not significant, representative microscopy images 
shown in Figure 3.18.A may provide further evidence that inhibiting autophagy with chloroquine 
in palmitate-treated cells may increase apoptosis further, while inhibiting ER stress with 
salubrinal in palmitate treatment may decrease apoptosis compared to palmitate. As expected, 
cells treated with H2O2 as a positive control, showed significantly more apoptosis than the 
control condition.  
 
Lastly an MTT cell viability assay yielded similar observations. Figure 3.19 illustrates that 
24h Pal significantly decreased cell viability compared to control, while inhibiting ER stress with 
salubrinal in the palmitate treatment significantly increased cell viability compared to palmitate 
alone. Though not statistically significant, the inhibition of autophagy with chloroquine in the 
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palmitate treatment appeared to demonstrate a trend towards reducing cell viability further than 
palmitate. H2O2-treated cells elicited significantly less cell viability than any of the other 
conditions. 
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Figure 3.17. Apoptosis in L6 wt myoblasts as assessed by cleaved caspase 3 Western blot  
(A) Western blot images, from individual experiments, for time point 24h  
(B) Corresponding Western blot quantification graphs for individual experiments shown in (A). In upper 
graph, data columns illustrate mean±SEM of the duplicates for each condition.  
(C) Cumulative graph of Western blot quantification | n=2 | Pal and Tun seem to increase cleaved 
caspase 3 compared to control. Inhibiting autophagy with Chl in both control and Pal conditions seems to 
increase cleaved caspase 3 further, while inhibiting ER stress with Sal in Pal treatment appears to 
decrease cleaved caspase 3 compared to Pal, at least in the upper graph of (B). 
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Figure 3.18. Apoptotic cells, as assessed by Caspase 3/7 Green Detection Reagent Microscopy 
(A) Representative microscopy images at 24h time point  
(B) Quantification of images done by calculating the mean percentage of apoptotic cells exhibiting a 
nuclear green fluorescence signal | n=3 for con, Pal, Chl+con, Chl+Pal, Sal+con, Sal+Pal; n=2 for H2O2 | 
24h Pal significantly increases the quantity of apoptotic cells i.e. those cells showing green nuclear 
fluorescence compared to 24h Con, as denoted by * (p<0.05). Palmitate condition pretreated with 
chloroquine significantly increases quantity of apoptotic cells compared to control condition pretreated 
with chloroquine, as denoted by # (p<0.05). Statistical analysis done by Kruskal-Wallis test with Dunn’s 
multiple comparison post-hoc test. | Though statistically not significant in the graph, a trend might be 
demonstrated and visualized in the representative microscopy images that inhibiting autophagy with Chl 
in Pal treatment seems to increase apoptosis further than Pal, while inhibiting ER stress with Sal in Pal 
treatment appears to decrease apoptosis compared to Pal. | H2O2 causes significantly more apoptosis 
than control, as denoted by * (p<0.05), analyzed by Mann-Whitney U test.  
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Figure 3.19. Cell viability as assessed by MTT Assay in L6 wt myoblasts | n=4 for con, Pal, H2O2; n=3 for 
Chl+con, Chl+Pal, Sal+con, Sal+Pal | 24 Pal demonstrates significantly less cell viability than 24h Con, 
denoted by * (p<0.05). Salubrinal pretreatment prior to palmitate significantly increases cell viability, as 
compared to palmitate, denoted by # (p<0.05). H2O2, the positive control for cell death, demonstrates 
significantly less cell viability than any of the other conditions, denoted by $ (p<0.05). Statistical analyses 
done by Mann-Whitney U test. Though not statistically significant, inhibiting autophagy with chloroquine in 
palmitate treatment appears to demonstrate a trend towards reducing cell viability further than palmitate. 
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3.4. Adiponectin Regulates ER stress, Autophagy and Apoptosis  
 
3.4.1. Introduction 
 
As discussed in Chapter 1, Section 1.5, although adiponectin usually circulates in the 
blood of healthy individuals at high concentrations of between 3-30µg/ml, thereby accounting for 
approximately 0.01% of total serum proteins [110, 136], its expression and serum levels have 
been found to be decreased in conditions of obesity [136], type 2 diabetes [99], dyslipidemia 
[100], cardiovascular disease [101], hypertension [102], cancer [103] and non-alcoholic 
steatohepatitis [104]. Given the importance that its deficiency has in the pathogenesis of such 
disorders, much research in the field has focused on upregulating adiponectin action, and has 
found that it mediates several beneficial effects through its antidiabetic, anti-inflammatory, 
antiatherogenic, and cardioprotective properties [136]. Now new insights are being gained into 
how adiponectin may mediate its protective outcomes via regulating the cellular processes of 
ER stress, autophagy, oxidative stress and apoptosis, and this research will be discussed here.  
 
Liu et al [110] demonstrated that treating high-fat diet (HFD) fed-adiponectin knockout 
(AdKO) mice with adiponectin attenuated skeletal muscle insulin resistance by stimulating 
autophagy and antioxidant potential. Increased levels of autophagic proteins LC3II, Beclin 1 and 
ULK1 were observed, along with a decrease in p62, which indicated upregulation of autophagic 
flux. In addition, oxidative stress induced by HFD was corrected by adiponectin, while temporal 
analysis of glucose tolerance and insulin sensitivity using hyperinsulinemic-euglycemic clamp 
and muscle IRS and Akt phosphorylation demonstrated that AdKO mice with adiponectin 
replenishment exhibited less HFD-induced insulin resistance than AdKO control mice.   
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Adiponectin-stimulated autophagy was also found by Nepal et al [137] to have a 
protective role in reducing apoptosis induced by ethanol in liver cells. In that study in primary rat 
hepatocytes and HepG2 cells, ethanol suppressed the expression of Atg5, necessary for 
autophagosome elongation. Adiponectin treatment was demonstrated to restore this and was 
additionally found to increase p62 degradation in HepG2 cells, which the authors interpreted to 
indicate completion of autophagic flux. Secondly, siRNA targeting Atg5 was found to 
significantly inhibit the protective effect that adiponectin had in rescuing HepG2 cells from 
apoptosis caused by ethanol, as assessed by MTS assay and analysis of caspase 3 activation. 
Hence autophagy induced by adiponectin was found to protect cells from cytotoxicity. 
   
 Amelioration of apoptosis by adiponectin has additionally been demonstrated to occur by 
downregulation of ER stress. For example, the apoptosis induced by hyperglycemia in human 
glomerular podocytes was found to be decreased by 10% when adiponectin was administered. 
This reduction in cell death was accompanied by a downregulation of mRNA and protein 
expressions of key ER stress-related proteins GRP78, CHOP and caspase 12 [138]. Similarly in 
Wistar rats exposed to chronic intermittent hypoxia (CIH), cardiac left ventricular dysfunction 
and myocardial apoptosis were found to be rescued by adiponectin (Ad) treatment as assessed 
by echocardiograph and TUNEL analysis respectively. Protein expression levels of cleaved 
caspase 3, cleaved caspase 9 and cleaved caspase 12 were also decreased in the CIH+Ad 
group. These results correlated with decreased expression of GRP78, CHOP and reactive 
oxygen species (ROS), thereby indicating that adiponectin protected against cardiac dysfunction 
and apoptosis by inhibiting ROS-dependent ER stress [139].  
 
 Therefore, it is evident that a rapidly growing body of literature has begun to characterize 
the role of adiponectin in regulating autophagy, ER stress and apoptosis. The goals of this study 
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were to examine the hypothesis that adiponectin upregulates autophagy, and downregulates ER 
stress and apoptosis, and to determine the relationships between regulation of these processes 
by adiponectin in my model of L6 rat skeletal muscle cells.  
 
3.4.2. Results 
 
 
3.4.2.1. Adiponectin appears to increase autophagy, as evidenced by apparent 
increased autophagosome formation and lysosome activity 
 
Figure 3.20 shows that fAd appears to increase the expression of LC3II, a key 
autophagosome marker, compared to control at both 1h and 2h. However, p62 levels appear 
approximately the same across all conditions. Figure 3.21 demonstrates that in independent 
experiments for time points 4h and 24h, the addition of fAd in the control condition as well as in 
the palmitate treatment, appears to increase lysosomal activity compared to the non-fAd control 
and the non-fAd palmitate, as evidenced by apparent increased red fluorescence of active 
cathepsin B enzyme. These results collectively indicate that adiponectin may stimulate 
autophagic flux by increasing autophagosome formation and lysosome activity. 
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Figure 3.20. Analysis of autophagic flux markers, LC3II and p62 by Western blot 
(A) Western blot image for L6 wt myoblasts for time points 1h, 2h  
(B) Quantification graph of Western blot shown in (A) | n=1 | fAd appears to increase LC3II compared to 
control, which corresponds to an increase in autophagosome formation.   
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Figure 3.21. Adiponectin appears to stimulate autophagy as evidenced by Magic Red Cathepsin B Assay 
microscopy  
(A) Microscopy images for time point 4h | n=1 | fAd pretreatment prior to both 4h Con and 4h Pal appears 
to increase lysosomal activity compared to 4h Con and 4h Pal  
(B) Representative images for time point 24h | n=4 | fAd pretreatment prior to both 24h Con and 24h Pal 
appears to increase lysosomal activity compared to 24h Con and 24h Pal.  
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3.4.2.2. Adiponectin appears to reduce ER stress induced by palmitate, as 
evidenced by apparent decreased cellular protein aggregation and 
GRP78mcherry expression  
 
 Figure 3.22A demonstrates that fAd pretreatment prior to 24h Pal appears to 
reduce the amount of protein aggregation visualized via ThT assay compared to 24h 
Pal. In keeping with results from Chapter 2, spectrometry analysis of ThT fluorescence 
(Figure 3.22B) illustrates that 24h Pal significantly increases protein aggregation 
compared to control. It is observed that 24h fAd also significantly increases protein 
aggregation compared to control. When fAd is added as a pretreatment to 24h Pal, it 
appears to blunt the protein aggregation caused by palmitate. Furthermore, Figure 3.23 
shows that fAd pretreatment prior to 24h Pal significantly decreases the red 
fluorescence of the GRP78mcherry reporter construct compared to 24h Pal. 
Collectively, these results may indicate that fAd may reduce ER stress. 
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Figure 3.22. Adiponectin may demonstrate a trend towards reducing protein aggregation caused by 
palmitate’s induction of ER stress, as assessed by ThT Assay  
(A) Representative image for ThT Microscopy in L6 wt myoblasts | 24h | n=1 | fAd pretreatment prior to 
24h palmitate may be seen to demonstrate a trend towards reducing green fluorescence of ThT, 
indicating protein aggregation, compared to 24h palmitate 
(B) ThT Spectrometry graph from L6 wt myotubes | 24h | n=6 for con, Pal; n=4 for fAd, fAd+Pal; n=5 for 
Tun | 24h palmitate significantly increases protein aggregation compared to control, denoted by * 
(p<0.05). fAd pretreatment prior to both control and palmitate significantly increases protein aggregation 
compared to control, denoted by * (p<0,05). Though not statistically significant, a trend towards a slight 
decrease in protein aggregation may be observed between the palmitate condition and palmitate 
pretreated with fAd. Statistical analysis done by one-way ANOVA with Tukey’s post hoc test. Normal 
distribution verified by Kolmogorov-Smirnov and Shapiro Wilk tests. 
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Figure 3.23. Adiponectin reduces GRP78mcherry expression in palmitate condition, providing evidence 
that it may reduce the ER stress induced by palmitate  
(A) Representative image for GRP78mcherry microscopy 
(B) Quantification graph of GRP78mcherry microscopy using Image J software. Each column represents 
the mean of 30-50 cells | 24h | n=3 | 24h palmitate and 24h tunicamycin significantly increase overall red 
fluorescence of GRP78mcherry reporter construct compared to 24h control, denoted by * (p<0.05). fAd 
pretreatment prior to both control and palmitate significantly increases overall red fluorescence compared 
to 24h control, denoted by * (p<0.05). fAd pretreatment prior to palmitate significantly decreases red 
fluorescence  compared to palmitate, as denoted by # (p<0.05). | Statistical analysis done by Kruskal-
Wallis test with Dunn’s multiple comparison post-hoc test. 
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3.4.2.3. Adiponectin reduces apoptosis induced by palmitate, as assessed by 
Caspase 3/7 Green Detection Reagent Microscopy  
 
 It can be observed in Figure 3.24, that while 24h Pal significantly increases the mean 
percentage of apoptotic cells compared to the control (p<0.05), fAd pretreatment prior to 24h 
Pal significantly decreases the quantity of apoptotic cells compared to 24h Pal. 
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Figure 3.24. Adiponectin reduces apoptosis caused by palmitate, as assessed by Caspase 3/7 Green 
Detection Reagent Microscopy  
(A) Representative microscopy images 
(B) Quantification of images done by calculating the mean percentage of apoptotic cells exhibiting a 
nuclear green fluorescence signal | 24h | n=3 | Pal significantly increases quantity of apoptotic cells 
compared to control, denoted by * (p<0.05). fAd pretreatment prior to Pal significantly decreases the 
quantity of apoptotic cells, compared to Pal, denoted by # (p<0.05). Statistical analyses done by Mann-
Whitney U test.   
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Chapter 4: Discussion 
 
4.1. Effect of Palmitate on ER Stress and Autophagy  
 
The direct link between obesity-induced lipotoxicity and ER stress has been well 
described [140], with several articles showing that saturated fatty acids like palmitate cause 
protein accumulation [43] and upregulation of UPR protein markers [44, 45, 47]. My studies also 
support these findings, as palmitate treatment was seen to significantly increase protein 
aggregation and GRP78 chaperone expression, while also significantly increasing the UPR 
protein peIF2α at the 24h time point. ThT analysis of protein aggregation, used initially in 
studies of Alzheimer’s disease where the dye provided visualization of B-sheets [141], was first 
described as a new tool for investigating ER stress induced by thapsigargin in Beriault & 
Werstuck [36]. Here I have shown that it may be used effectively to study and quantify ER 
stress induced by saturated fatty acids like palmitate in skeletal muscle cells. 
 
 As discussed earlier in Section 2.1, there has been some conjecture in the field 
regarding whether conditions of high-fat, obesity and lipotoxicity stimulates [58, 125] or inhibits 
[126] autophagic flux. My studies appear to support the former assertion, as apparent increases 
in LC3II expression, along with an increase in lysosomal activity are evident in palmitate 
conditions. In addition, though quantitative analysis for the LC3 immunofluorescence assay is 
required, the images may visually show an increase in autophagosome formation, evidenced by 
an increase in green puncta in palmitate conditions. Indeed, autophagy has been shown to 
become activated in response to moderate lipid overload in the cell where it specifically targets 
lipids for degradation through lipophagy [58], or it has also been shown to be activated in 
response to fatty-acid induced-protein overload to help rid the cell of excess proteins [44]. It may 
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be noted from the LC3 immunofluorescence images that nuclei appeared green, and this was 
found not be an artifact of microscopy imaging caused by potential bleed through of DAPI and 
simultaneous excitation of both blue and green wavelengths, as an additional experiment was 
performed that demonstrated that even when DAPI staining was absent, the nuclei still 
fluoresced green. This might indicate a true presence of LC3 in nuclei, as corroborated by 
Martinez-Lopez & Singh [142] who propose the role of autophagic structures as nuclear 
scaffolds for MAPK phosphorylation.  
 
4.2. ER Stress May Induce Autophagy as a Rescue Mechanism  
 
 The sequential link between ER stress and autophagy proposed previously in the 
literature [76], appeared to be confirmed in this study using L6 skeletal muscle cells. First, ER 
stress induced by tunicamycin was found to correspond to an apparent upregulation of LC3II 
and an apparent decrease in p62 by Western blotting. Furthermore, after 4h, an apparent 
increase in lysosomal activity was indicated by cathepsin B enzyme activity. The increase in 
autophagic stimulation observed after ER stress is well supported in the field as studies utilizing 
ER stressors thapsigargin, tunicamycin and polyglutamine 72 (PolyQ72) aggregates have 
shown increased conversion of LC3I to LC3II[39, 75, 127, 129]. Additionally, ER stress induced 
by hypoxia-ischemia in neonatal rats showed increased expression in brain tissue of not only 
LC3 II, but also Beclin 1, another protein involved in autophagosome assembly. Enhancing 
autophagy in these animals with rapamycin significantly reduced ER stress proteins GRP78 and 
CHOP, thereby indicating that autophagy may act to alleviate ER stress [143]. 
 
I also found that pretreatment with salubrinal in both control and palmitate conditions 
appeared to increase cathepsin B lysosomal activity. These findings indicate that autophagy 
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may be upregulated as a part of UPR downstream adaptive signaling, specifically by sustained 
phosphorylation of eIF2α and prolonged activation of its pathway by salubrinal. This is in 
keeping with reports such as Kouroku et al [75] that demonstrated that the PERK/eIF2α 
pathway has an imperative role in the induction of autophagy. In C2C5 cells, stimulated to 
undergo ER stress by PolyQ, eIF2α phosphorylation was demonstrated to upregulate Atg12 
mRNA and protein, which was necessary for Atg5-Atg12-Atg16 complex-dependent LC3I to 
LC3II conversion. In addition, when the PERK/peIF2α pathway was inhibited, by either an eIF2α 
A/A mutation which replaced a phosphorylatable Ser51 with Ala51, or by using a dominant-
negative PERK, PolyQ72-induced LC3 conversion was inhibited [75].   
 
Lastly, exacerbation of ER stress upon impairment of autophagy was demonstrated in 
this study and provided further evidence for the protective role that autophagy plays in 
ameliorating ER stress. There was greater apparent accumulation of protein aggregates, as 
indicated by ThT Assay, and significantly greater peIF2α expression, as indicated by Western 
blotting, in ATG5K130R compared to EV cells. In control and palmitate conditions pretreated 
with chloroquine, significantly greater expression of GRP78mcherry reporter construct was 
observed than in control or palmitate alone. These results all indicated that with an impairment 
in the autophagic pathway, either induced in the early stage with defective ATG5K130R protein 
or in the later stage with chloroquine, ER stress may have become aggravated. Undegraded 
proteins appeared to accumulate more in the absence of the autophagic degradative outlet and 
the UPR was found to be upregulated. These findings are in line with studies such as Kouroku 
et al [75] which similarly found that Atg5 deficiency increased the number of C2C5 cells showing 
polyQ72 aggregates. Carloni et al [143] reported that the decrease in expression of GRP78 
observed when hypoxic-ischemic neonatal rats were treated with rapamycin, an autophagy 
inducer, was completely reversed when they were exposed to 3-MA, an autophagy inhibitor.   
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4.3. Prolonged, Excessive, or Uninhibited ER Stress Induces 
Apoptosis  
 
In this study of L6 rat skeletal muscle cells, my data suggested that apoptosis caused by 
tunicamycin occurred, at least in part, specifically through ER stress. This is based on results 
showing that tunicamycin appeared to increase expression of the ER-resident caspase 12 by 
Western blot. Caspase 12 has been shown to be activated only in apoptosis caused by ER 
stress-inducing stimuli such as tunicamycin, and loss of caspase 12 has been shown to inhibit 
ER stress-mediated apoptosis [133]. Tunicamycin effectively induces ER stress, as it blocks N-
glycosylation, thereby leading to accumulation of unfolded glycoproteins in the ER [38], and it 
has previously been shown to induce caspase 12 activation in several cell types and models 
[133, 144, 145], therefore supporting my findings here.  
 
Additionally, both tunicamycin and palmitate were found in this study to apparently 
increase the expression of cleaved caspase 3, an executioner caspase. Furthermore, palmitate 
significantly increased the mean percentage of apoptotic cells, assessed by microscopy using 
caspase 3/7 green detection reagent assay. This is in keeping with results from various reports 
that have shown similar upregulation of caspase 3 by tunicamycin and palmitate [44, 146]. It is 
of interest that some research in the field has indicated that caspase 3 might be activated by 
caspase 12 in response to ER stress. As discussed previously, Hitomi et al [135] has 
demonstrated that when treated with tunicamycin, cleavage of procaspase 3 was significantly 
increased in SK-N-SH cells that stably expressed caspase 12 compared to empty vector cells 
[135]. In addition, Morishima et al [147] has shown that in C2C12 cells, recombinant caspase 12 
cleaves and activates procaspase 9, since mutation of specific Asp residues in the proscaspase 
9 polypeptide significantly reduced cleavage by caspase 12. Active caspase 9 is then noted to 
catalyze the cleavage of procaspase 3 [147]. Hence, it is possible that the caspase 3 apoptotic 
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signaling apparently induced by palmitate and tunicamycin in the current model of L6 rat 
skeletal muscle cells may originate from ER stress-mediated caspase 12 apoptotic signaling.  
 
When autophagy was inhibited with chloroquine in combination with palmitate treatment, 
cleaved caspase 3 expression appeared to be increased. The quantity of apoptotic cells 
visualized by localization of green fluorescence in nuclei also showed an apparent increase, and 
cell viability assessed by MTT assay showed an apparent decrease. This may be because with 
the impairment in the autophagic pathway induced by chloroquine, ER stress caused by 
palmitate as evidenced from results in Chapter 2, may be too much for the cell to cope with. The 
inhibition of autophagic flux would reduce the amount of proteins that could be degraded and 
would instead exacerbate ER stress, therefore inducing ER-stress mediated apoptosis. This 
suggestion is supported by studies like Xu et al [148] which demonstrated that while cisplatin 
treatment in HeLa cells normally induced degradation of ubiquitinated proteins by autophagy, 
thus reducing ER stress-induced apoptosis and the mitochondrial pathway of apoptosis, 
inhibition of autophagy with 3-MA or chloroquine upregulated the quantity of intracellular 
misfolded proteins, thereby increasing apoptosis [148]. An additional reason why inhibiting 
autophagy in palmitate treatment, might enhance apoptosis, might have to do with the 
downregulation in mitophagy that would follow. As discussed in Chapter 1, Section 1.4.3.1, 
cellular stressors may damage mitochondria and induce MOMP, releasing various proapoptotic 
factors into the cytoplasm. However the output of these proapoptotic factors might be decreased 
through mitophagy, a sub-type of autophagy that selectively targets damaged mitochondria for 
degradation [84, 85]. Since palmitate has been known to damage mitochondria in various ways 
such as by direct effects such as dissipating the mitochondrial transmembrane potential and 
causing the release of soluble apoptotic factors [149], by causing mitochondrial reactive oxygen 
species generation [47], and by converting to ceramide and inhibiting mitochondrial respiratory 
93 
 
chain complexes I and III [67], the inhibition of mitophagy by any autophagic inhibitor may 
indeed increase apoptosis. 
 
 The inhibition of ER stress through the maintenance of the activity of the peIF2α 
pathway of the UPR with salubrinal, appeared to decrease apoptosis as evidenced by caspase 
3 Western blot, caspase 3/7 microscopy images and MTT cell viability assay. This might be 
because, as indicated in Chapter 3, section 3.4, the continued phosphorylation of eIF2α 
facilitated by salubrinal, may enable the continued activation of cytoprotective autophagy. This 
is possible because the activated peIF2α pathway upregulates Atg12 mRNA and protein, which 
plays a role in Atg5-Atg12-Atg16 complex-dependent LC3I to LC3II conversion, a central step in 
the induction of autophagy [75]. 
 
Collective consideration of the results of Chapters 2, 3 and 4 may elucidate a key trend – 
that prolonged exposure to palmitate or tunicamycin induces ER stress, and in the absence of 
an adequate autophagic protective mechanism, apoptotic signaling might be induced.  As 
evidenced in Chapter 2 findings, a longer exposure of 48h to palmitate and tunicamycin 
significantly increased GRP78mcherry expression compared to 24h, and in addition, the 
expression of peIF2α by Western blotting appeared to increase over time i.e. from 4h to 24h 
exposure to palmitate. While ER stress seemed to increase over time, autophagy only appeared 
to be upregulated in the relative short term. As illustrated in Chapter 2, cathepsin B activity, 
indicative of lysosomal activity, was significantly enhanced at 4h and 24h Pal, but not 48h Pal, 
compared to corresponding controls. This enzyme activity also decreased with prolonged 
exposure to palmitate, showing significant reductions from 4h to 24h to 48h. With tunicamycin 
treatment, at 4h, the cathepsin B activity appeared greater compared to control, while 24h Tun 
did not elicit much difference from its control. With regards to apoptosis, it appeared that greater 
expression of cleaved caspase 3 induced by palmitate and tunicamycin, occurred at the longer 
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exposure time of 24h than at 4h. These results appear to indicate that autophagy may act 
acutely to rescue ER stress, but with prolonged ER stress, autophagy may not be able to cope 
anymore and apoptosis may take over. As noted in Chapter 1, Section 1.4.3.2, once apoptosis 
is underway, its caspase activity may in fact inactivate the autophagic pathway through 
digestion of essential autophagy proteins [91]. Several examples in the literature support this 
line of thinking. Gonzalez-Rodriguez et al [150] has shown that treatment of Huh7 human 
hepatic cells with palmitate for 8h activated both the UPR and autophagic flux, but a longer 
treatment for 24h induced ER stress and cell death, while inhibiting autophagic flux. Similarly, in 
HepG2 cells treated with thapsigargin to induce ER stress and rapamycin to induce autophagy, 
it was found that with a shorter exposure to thapsigargin for 2h, autophagy was adaptively 
upregulated to decrease stress levels, and increase cell viability. This was evidenced by an 
increase in LC3I to LC3II conversion. However with a longer 24h exposure to thapsigargin, 
autophagy became inhibited, as evidenced by an increase in p62, while apoptosis was 
upregulated, as evidenced by induction of PARP cleavage and reduction in procaspase 3 [151].  
 
4.4. Adiponectin Regulates ER Stress, Autophagy and Apoptosis 
 
 As supported by the literature described previously, that demonstrates that adiponectin 
increases autophagic flux [110, 137], the results of this study illustrated that L6 wt myoblasts 
treated with adiponectin, appeared to have increased LC3II expression compared to control 
cells at both 1h and 2h. In addition, adiponectin in both control and palmitate conditions for 4h 
and 24h, appeared to increase lysosomal activity as evidenced by apparent increased 
lysosomal protease cathepsin B activity. Liu et al [110] provides specific corroboration for these 
trends, as in cultured L6 myoblasts, increased LC3II expression and increased lysosomal 
enzyme activity were found to be facilitated by adiponectin in an AMPK-dependent manner.   
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 Adiponectin’s apparent effect in decreasing ER stress induced by palmitate, evidenced 
by apparent reduced protein aggregation and significant reduced GRP78 expression, is 
supported by studies [138, 139] that show similar decreases in GRP78 expression as well as 
decreases in more downstream markers of ER stress-induced apoptosis, namely CHOP and 
caspase 12, after adiponectin intervention. In addition, adiponectin’s role in attenuating ER 
stress was further extended by Guo et al [152] who showed that it conferred resistance to ER 
stress and cardiomyocyte injury induced by ischemia/reperfusion in rats by modulating ER Ca2+-
ATPase (SERCA) activity via activation of PI3K/Akt signaling [152]. The same study also found 
that adiponectin reduced expression of GRP78, CHOP and caspase 12, which had been 
upregulated by hypoxia/reoxygenation and thapsigargin [152]. However it was also observed 
that adiponectin added to the control condition increased protein aggregation. Such an effect of 
adiponectin has been previously unreported in the literature and the significance of such a 
finding remains unknown.  
 
 The protective effect of adiponectin in guarding against apoptosis was demonstrated by 
the significant reduction in quantity of cells exhibiting caspase 3/7 activity in the palmitate 
condition pretreated with adiponectin, compared to palmitate alone. Several studies have shown 
that adiponectin may mediate its cytoprotective effect by upregulating autophagy and 
decreasing oxidative and ER stress [137, 138, 139, 117, 152]. In addition, an interesting study 
by Lin et al [153] demonstrated further insights into how adiponectin’s stimulation of autophagy 
might mediate its cytoprotective effects. Liver cells of AdKO mice and primary hepatocytes, 
stressed with acetaminophen overdose, demonstrated aggravated mitochondrial dysfunction 
and damage, oxidative stress and necrosis. However administration of adiponectin was found to 
stimulate autophagosome formation in an AMPK-dependent manner, which led to the increased 
degradation of damaged mitochondria via mitophagy. Accumulation of ROS was also reduced, 
as were other indicators of mitochondrial damage such as serum mtDNA levels, 
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phosphorylation of mitochondrial JNK, and dysfunction of mitochondrial respiratory chain 
complexes [153].  
 Therefore, in my study it may be concluded that adiponectin pretreatment prior to 
palmitate, may mediate beneficial effects by upregulating autophagy. Such an outcome would 
be adaptive as autophagy may rescue palmitate-induced ER stress and protein accumulation as 
demonstrated in Chapter 3, and therefore ameliorate ER stress-induced apoptosis as was 
discussed in Chapter 4. As suggested by the literature described previously, adiponectin may 
bring about these results by decreasing expression of ER stress-related proteins GRP78, CHOP 
and caspase 12 [138, 139, 152], in addition to potentially stimulating removal of damaged 
mitochondria through mitophagy [153] and downregulating activation of caspase 3 [139]. Indeed 
the current study showed an apparent increase in autophagy, accompanied by apparent 
decreases in GRP78 expression and activity of caspase 3/7. In addition to boosting the n 
number of the current preliminary data, analysis of CHOP, caspase 12 and mitophagy markers 
could be conducted in future experiments to further investigate these mechanisms.     
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Chapter 5: Summary 
 
5.1. Overview of Results  
 
The research presented in this project may extend our understanding of the effects of 
palmitate-induced lipotoxicity in L6 rat skeletal muscle cells. Though some of the data requires a 
higher number of experiments to confer statistical significance, there are noticeable trends that 
emerge from combined consideration of the various experiments and assays conducted so far 
which build a case for the conclusions made. In particular, I have elucidated the mechanisms 
involved in the cross talk between ER stress, autophagy and apoptosis (Figure 5.1). I have 
shown that palmitate induces excessive protein accumulation in the cell, thereby causing ER 
stress and activation of the UPR. Autophagy may be recruited as a compensatory mechanism 
downstream of phosphorylation of PERK/eIF2α in the UPR, to help the cell cope with the stress 
induced by protein overload through its degradative pathway. However when stress levels 
exceed the adaptive capabilities of the cell, apoptotic signaling may overwhelm the system and 
inhibit protective outputs such as autophagy, leading the cell to its demise. Additionally, 
adiponectin may play a facilitatory role in ameliorating these processes, as I have shown that it 
may increase autophagic flux and contribute to beneficial cellular cytoprotective effects of 
reducing ER stress and apoptosis.  
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Figure 5.1. Effect of palmitate-induced lipotoxicity on ER stress, autophagy and apoptosis and regulation 
by adiponectin in L6 skeletal muscle cells. Palmitate induces ER stress and activation of the UPR. 
Autophagy may be recruited as a compensatory mechanism downstream of phosphorylation of 
PERK/eIF2α in the UPR, to inhibit EFpeR stress. However if autophagy is inhibited through the use of 
molecular or pharmacological approaches, such as using ATG5K130R dominant negative mutant or 
chemical inhibitor chloroquine, and/or ER stress exceeds the adaptive capabilities of the cell, apoptotic 
signaling may be induced. Adiponectin may stimulate autophagy and therefore ameliorate the processes 
of ER stress and apoptosis.  
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5.2. Future Directions  
 
Lipotoxicity in skeletal muscle has long been established to contribute to the 
development of insulin resistance and impairment of glucose metabolism that is characteristic in 
metabolic disorders such as type 2 diabetes and obesity [23, 154], and recent studies have now 
been exploring the role of lipotoxicity-induced ER stress [47, 155], autophagy [110] and 
apoptosis [71] in mediating these metabolic effects. Hence I would be most interested in 
furthering the scope of my project to verify the effect of palmitate and adiponectin intervention 
on insulin-signaling and glucose uptake, which previous studies have shown are inhibited in 
conditions of obesity [12, 22, 23]. I would perform Western blots for key proteins involved in 
intracellular insulin signaling such as IR (insulin receptor), phospho IRS (Y612; phosphorylation 
of insulin receptor substrate) and phospho Akt (S473 and T308) [23, 110]. Glucose uptake and 
GLUT4 translocation would be measured as described in Fang et al [117].  
 
Another important cellular process, oxidative stress with its contingent production of free 
radicals and impaired antioxidant defence [156], has been implicated in the pathogenesis of 
skeletal muscle insulin resistance and mitochondrial dysfunction induced by lipotoxicity [157], 
and adiponectin has been shown to regulate this [110]. Investigating the effects of palmitate and 
adiponectin in L6 rat skeletal muscle cells on the levels of major anti-oxidative enzymes such as 
superoxide dismutase, catalase and glutathione peroxidase, using assays established in our lab 
and described in Liu et al [110], would provide a valuable perspective on the progression of 
metabolic dysfunction observed in diabetes and obesity. It would also be of interest to study the 
cross talk between oxidative stress, ER stress, autophagy and apoptosis in a lipotoxic skeletal 
muscle model, to further insights provided by other studies in the field that have linked these 
processes [158, 159]. To do this, I would again use methods that have been recently developed 
in our lab. As tunicamycin and palmitate have been shown in my studies to elicit apparent 
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increases in ER stress, autophagy and apoptosis, I would check if these increases might be 
accompanied by increased oxidative stress as detected by CellROX Deep Red reagent and 
CellROX Green reagent (Life Technologies) that are fluorogenic, cell-permeant dyes which 
exhibit enhanced fluorescence upon oxidation by reactive oxygen species. In addition, the use 
of inhibitors, chloroquine for autophagy and N-acetyl-cysteine for oxidative stress, would show 
whether the inhibition of one process has any effects on the upregulation or downregulation of 
the other processes, and thereby help discern mechanistic relationships between them. 
 
As it is established that lipotoxicity mediates harmful effects to the cell through ER stress 
and oxidative stress, which damage mitochondria and thereby induce apoptosis, the study of 
mitophagy, the selective degradation of damaged mitochondria by autophagy, has come to be 
recognized as an important protective mechanism for the cell [84, 85]. Mitophagy increases 
adaptive turnover of aberrant mitochondria, reduces abnormal mitochondrial functioning and 
inhibits the release of proapoptotic factors such as AIF, EndoG, SMAC and cytochrome c into 
the cytoplasm [84, 85, 158]. Hence verifying whether mitophagy specifically is upregulated in L6 
skeletal muscle cells by palmitate and adiponectin, rather than simply generic macroautophagy, 
would help to further flesh out the findings of this project. To this end, I would conduct Western 
blotting for key proteins necessary for mitophagy, such as Pink1 and Parkin, which are involved 
in priming damaged mitochondria for selective autophagic recognition, transmission electron 
microscopy (TEM) analysis to visualize the stages of mitophagy such as the early stage which 
would be recognizable by the double membraned autophagosomal structure containing 
mitochondria detectable by their characteristic cristae, and fluorescence microscopy in which 
colocalization could be observed between mitochondria discernable by MitoTracker and 
autophagosomes discernable by GFP-LC3 [160].    
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In addition to the courses of study outlined above that could be pursued to broaden the 
scope of this project, other specific assays that have been recently established in our lab, could 
be conducted to gain further insight into the current observations that have been made in this 
thesis report. Microscopy work could be extended in the following ways: transmission electron 
microscopy (TEM) analysisis still regarded as a gold standard in studying autophagy and would 
enable visualization of autophagosomes during autophagy. TEM can also detect additional 
features of the cell architecture, such as extension and swelling of the rough endoplasmic 
reticulum during ER stress [44]. Specific analysis of autolysosomes could be achieved using a 
compound consisting of fluorescent BODIPY dye conjugated to bovine serum albumin (DQ-
BSA) that is self-quenched, but when engulfed by the cell and proteolysed by lysosomal 
proteases, becomes dequenched and releases brightly fluorescent protein fragments. The use 
of DQ-BSA in conjunction with immunofluorescence of p62, a characteristic autophagic marker 
described previously, would enable detection of the actively degradative autolysosome, through 
demonstration of the convergence between an autophagic compartment and functional 
lysosome[161]. Autophagic flux could be examined in more depth using the L6 skeletal muscle 
cell line stably overexpressing RFP/GFP-LC3. In this approach, GFP but not RFP, would be 
sensitive to quenching by the acidic environment of the autophagolysosome. Completion of 
autophagic flux can therefore be established when merged images exhibit maintained red and 
decreased green fluorescence [110].  
 
Moreover, to further solidify the statements I have made from the data presented in this 
thesis, the following additions to the existing experiments may be made. To provide support that 
ER stress may induce autophagy as a rescue mechanism to help the cell cope with increased 
protein load, I could use rapamycin to upregulate autophagy and check whether it decreases 
protein aggregation via ThT assay, decreases GRP78mcherry expression and decreases 
peIF2α expression in Western blot. In addition, using salubrinal in the endogenous LC3 
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immunofluorescence assay should show increased green LC3 puncta, indicative of increased 
autophagosome formation. This would corroborate my thinking that maintaining the activity of 
the UPR’s peIF2α signaling pathway leads to upregulation of autophagy induction, as well as 
the statement that autophagy may be upregulated as a part of UPR downstream adaptive 
signaling, specifically as part of the pPERK/peIF2α pathway. Though I have demonstrated that 
tunicamycin and palmitate both appear to increase caspase 3 activation, and that tunicamycin 
appears to increase caspase 12 activation, my next step would be check if palmitate also 
increases caspase 12 activation. In addition, I would examine whether tunicamycin and 
palmitate both increase the level of CHOP expression. These combined results would provide 
further information as to whether tunicamycin and palmitate induce apoptosis specifically 
through ER stress. Lastly, to verify the cytoprotective effect of autophagy and its ability to 
circumvent ER stress-induced apoptosis, ATG5K130R cells, defective for autophagy could be 
treated with tunicamycin and palmitate and should show increased caspase 12 and caspase 3 
expression, increased quantity of apoptotic cells in the caspase 3/7 green detection reagent 
assay, and decreased cell viability in the MTT assay, as compared to EV control cells.  
 
5.3. Concluding Remarks  
 
In conclusion, my thesis project has elucidated the effects of palmitate-induced 
lipotoxicity on important cellular mechanisms ER stress, autophagy and apoptosis in L6 skeletal 
muscle cells. I have demonstrated how these processes may interact in conditions of cellular 
stress and how they might be regulated by adiponectin. However, as discussed in detail 
previously, there is much more that can be explored to broaden the scope of this project and to 
gather further evidence to support the insights made.  
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